[


  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "下列何者為急性腎損傷（AKI）最常見的原因分類？",
    "options": [
      { "key": "A", "text": "腎前性（prerenal）" },
      { "key": "B", "text": "腎實質性（intrinsic）" },
      { "key": "C", "text": "腎後性（postrenal）" },
      { "key": "D", "text": "免疫性" }
    ],
    "answer": "A",
    "explanation": "臨床上 AKI 最常見為腎前性原因（如低血容量、低灌流），其次才是腎實質性與腎後性。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "下列何者最有助於區分腎前性 AKI 與急性腎小管壞死（ATN）？",
    "options": [
      { "key": "A", "text": "血清鈉濃度" },
      { "key": "B", "text": "尿液鈉濃度與 FENa" },
      { "key": "C", "text": "血紅素" },
      { "key": "D", "text": "血清白蛋白" }
    ],
    "answer": "B",
    "explanation": "腎前性 AKI 通常尿鈉低、FENa <1%；ATN 則尿鈉高、FENa >2%。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "關於急性腎小管壞死（ATN），下列何者正確？",
    "options": [
      { "key": "A", "text": "最常由尿路阻塞造成" },
      { "key": "B", "text": "尿沈渣可見泥沙樣（muddy brown）圓柱" },
      { "key": "C", "text": "FENa 通常小於 1%" },
      { "key": "D", "text": "腎功能恢復通常非常迅速" }
    ],
    "answer": "B",
    "explanation": "ATN 常見於缺血或毒性傷害，尿沈渣可見泥沙樣圓柱；FENa 多大於 2%。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜甲 急性腎損傷（AKI）" },
    "stem": "急性腎損傷病人出現下列哪一項情況時，最需要考慮緊急透析？",
    "options": [
      { "key": "A", "text": "輕度血尿" },
      { "key": "B", "text": "代謝性酸中毒合併症狀" },
      { "key": "C", "text": "血肌酸酐輕微上升" },
      { "key": "D", "text": "尿量稍減少" }
    ],
    "answer": "B",
    "explanation": "AKI 透析適應症包含難以控制的酸中毒、高鉀、肺水腫、尿毒症狀（AEIOU）。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "慢性腎臟病（CKD）的定義，下列何者正確？",
    "options": [
      { "key": "A", "text": "腎功能異常持續超過 2 週" },
      { "key": "B", "text": "腎功能異常持續超過 1 個月" },
      { "key": "C", "text": "腎功能異常持續超過 3 個月" },
      { "key": "D", "text": "任何一次 eGFR 下降皆屬 CKD" }
    ],
    "answer": "C",
    "explanation": "CKD 定義為腎臟結構或功能異常持續至少 3 個月，且具臨床意義。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "下列何者最常見為慢性腎臟病的病因？",
    "options": [
      { "key": "A", "text": "腎結石" },
      { "key": "B", "text": "糖尿病" },
      { "key": "C", "text": "急性腎炎" },
      { "key": "D", "text": "腎腫瘤" }
    ],
    "answer": "B",
    "explanation": "糖尿病為全球 CKD 與末期腎病最常見原因，其次為高血壓。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "關於 CKD 併發症，下列何者正確？",
    "options": [
      { "key": "A", "text": "低血磷" },
      { "key": "B", "text": "次發性副甲狀腺亢進" },
      { "key": "C", "text": "高血鈣" },
      { "key": "D", "text": "紅血球增多症" }
    ],
    "answer": "B",
    "explanation": "CKD 常見高磷、低鈣與次發性副甲狀腺亢進，並伴隨腎性貧血。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CKD_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜乙 慢性腎臟病（CKD）" },
    "stem": "關於 CKD 病人的用藥原則，下列何者最恰當？",
    "options": [
      { "key": "A", "text": "所有藥物皆可照一般劑量使用" },
      { "key": "B", "text": "需依腎功能調整藥物劑量" },
      { "key": "C", "text": "避免使用所有降壓藥" },
      { "key": "D", "text": "只需注意抗生素" }
    ],
    "answer": "B",
    "explanation": "CKD 病人多數藥物需依 eGFR 調整劑量，以避免藥物蓄積與毒性。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_NS_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 腎病症候群" },
    "stem": "下列何者為腎病症候群（nephrotic syndrome）的典型表現？",
    "options": [
      { "key": "A", "text": "蛋白尿 < 1 g/day" },
      { "key": "B", "text": "顯著蛋白尿、低白蛋白血症、水腫" },
      { "key": "C", "text": "明顯血尿與 RBC casts" },
      { "key": "D", "text": "低血脂" }
    ],
    "answer": "B",
    "explanation": "腎病症候群以大量蛋白尿（>3.5 g/day）、低白蛋白血症、水腫與高血脂為特徵。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NS_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丙 腎病症候群" },
    "stem": "小兒最常見造成腎病症候群的腎小球疾病為何？",
    "options": [
      { "key": "A", "text": "FSGS" },
      { "key": "B", "text": "Membranous nephropathy" },
      { "key": "C", "text": "Minimal change disease" },
      { "key": "D", "text": "IgA nephropathy" }
    ],
    "answer": "C",
    "explanation": "小兒腎病症候群最常見為 minimal change disease，對類固醇治療反應佳。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NS_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丙 腎病症候群" },
    "stem": "關於 focal segmental glomerulosclerosis（FSGS），下列何者正確？",
    "options": [
      { "key": "A", "text": "多見於兒童，預後佳" },
      { "key": "B", "text": "病灶為所有腎小球均勻受損" },
      { "key": "C", "text": "常與成人腎病症候群相關，預後較差" },
      { "key": "D", "text": "不會進展為末期腎病" }
    ],
    "answer": "C",
    "explanation": "FSGS 多見於成人，部分腎小球與部分節段受損，對治療反應較差，易進展至 CKD。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_NEPR_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丁 腎炎症候群" },
    "stem": "腎炎症候群（nephritic syndrome）最具代表性的臨床表現為何？",
    "options": [
      { "key": "A", "text": "大量蛋白尿與高血脂" },
      { "key": "B", "text": "血尿、高血壓、腎功能惡化" },
      { "key": "C", "text": "無症狀蛋白尿" },
      { "key": "D", "text": "低血壓與多尿" }
    ],
    "answer": "B",
    "explanation": "腎炎症候群以血尿、紅血球圓柱、高血壓與腎功能下降為主要特徵。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NEPR_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丁 腎炎症候群" },
    "stem": "IgA 腎病變最典型的臨床表現為何？",
    "options": [
      { "key": "A", "text": "長期無症狀蛋白尿" },
      { "key": "B", "text": "上呼吸道感染後數週出現血尿" },
      { "key": "C", "text": "感染後 1–2 天內出現血尿" },
      { "key": "D", "text": "僅見於老年人" }
    ],
    "answer": "C",
    "explanation": "IgA 腎病變常在上呼吸道感染後短時間內（1–2 天）出現肉眼血尿。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_NEPR_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜丁 腎炎症候群" },
    "stem": "急性鏈球菌感染後腎炎（PSGN）最常見於下列哪一族群？",
    "options": [
      { "key": "A", "text": "新生兒" },
      { "key": "B", "text": "兒童" },
      { "key": "C", "text": "青壯年" },
      { "key": "D", "text": "老年人" }
    ],
    "answer": "B",
    "explanation": "PSGN 多發生於兒童，常在皮膚或咽喉感染後 1–3 週出現。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_ELECTRO_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜戊 腎因性電解質與酸鹼" },
    "stem": "慢性腎臟病病人最常見的酸鹼異常為何？",
    "options": [
      { "key": "A", "text": "代謝性鹼中毒" },
      { "key": "B", "text": "呼吸性酸中毒" },
      { "key": "C", "text": "代謝性酸中毒" },
      { "key": "D", "text": "呼吸性鹼中毒" }
    ],
    "answer": "C",
    "explanation": "CKD 因酸排泄能力下降，最常見為代謝性酸中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ELECTRO_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第一篇 腎內科｜戊 腎因性電解質與酸鹼" },
    "stem": "腎衰竭病人出現高血鉀時，下列何者為最立即的心臟保護處置？",
    "options": [
      { "key": "A", "text": "口服樹脂" },
      { "key": "B", "text": "胰島素合併葡萄糖" },
      { "key": "C", "text": "靜脈注射鈣劑" },
      { "key": "D", "text": "利尿劑" }
    ],
    "answer": "C",
    "explanation": "高血鉀合併心電圖變化時，首要為靜脈注射鈣劑以穩定心肌細胞膜。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_INF_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症" },
    "stem": "下列何者最符合敗血症（sepsis）的定義？",
    "options": [
      { "key": "A", "text": "單純感染合併發燒" },
      { "key": "B", "text": "感染合併器官功能障礙" },
      { "key": "C", "text": "感染合併低血壓且需升壓劑" },
      { "key": "D", "text": "任何血液培養陽性" }
    ],
    "answer": "B",
    "explanation": "Sepsis 定義為感染導致的失調性宿主反應並造成器官功能障礙；C 描述較接近 septic shock。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_INF_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症" },
    "stem": "疑似敗血症病人之初步處置，下列何者最優先？",
    "options": [
      { "key": "A", "text": "等待培養結果再給抗生素" },
      { "key": "B", "text": "立即給予經驗性抗生素並補液" },
      { "key": "C", "text": "先安排影像檢查" },
      { "key": "D", "text": "僅給退燒藥" }
    ],
    "answer": "B",
    "explanation": "敗血症治療核心為及早給予廣效經驗性抗生素與復甦補液，並同時取得培養。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_ABX_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜乙 抗生素原則" },
    "stem": "關於抗生素治療原則，下列何者正確？",
    "options": [
      { "key": "A", "text": "一開始即使用最窄效抗生素" },
      { "key": "B", "text": "培養結果出來後應適度降階（de-escalation）" },
      { "key": "C", "text": "症狀改善即可立刻停藥" },
      { "key": "D", "text": "所有感染療程長度相同" }
    ],
    "answer": "B",
    "explanation": "經驗性治療後，依培養與臨床反應進行降階可降低抗藥性與副作用。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_PNA_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎" },
    "stem": "社區型肺炎（CAP）最常見的致病菌為何？",
    "options": [
      { "key": "A", "text": "Pseudomonas aeruginosa" },
      { "key": "B", "text": "Streptococcus pneumoniae" },
      { "key": "C", "text": "MRSA" },
      { "key": "D", "text": "Candida albicans" }
    ],
    "answer": "B",
    "explanation": "肺炎鏈球菌仍是 CAP 最常見致病菌。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_PNA_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎" },
    "stem": "下列何者較符合院內型肺炎（HAP）的風險因子？",
    "options": [
      { "key": "A", "text": "未住院的健康成人" },
      { "key": "B", "text": "住院超過 48 小時" },
      { "key": "C", "text": "近期無抗生素使用" },
      { "key": "D", "text": "門診追蹤病人" }
    ],
    "answer": "B",
    "explanation": "HAP 定義為住院 ≥48 小時後發生的肺炎，致病菌與抗藥性風險較高。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染" },
    "stem": "造成社區型泌尿道感染最常見的致病菌為何？",
    "options": [
      { "key": "A", "text": "Enterococcus faecalis" },
      { "key": "B", "text": "Escherichia coli" },
      { "key": "C", "text": "Pseudomonas aeruginosa" },
      { "key": "D", "text": "Staphylococcus aureus" }
    ],
    "answer": "B",
    "explanation": "E. coli 為社區型 UTI 最常見致病菌。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染" },
    "stem": "關於單純性膀胱炎的治療，下列何者正確？",
    "options": [
      { "key": "A", "text": "一定需要靜脈抗生素" },
      { "key": "B", "text": "口服抗生素即可，療程較短" },
      { "key": "C", "text": "一律需住院治療" },
      { "key": "D", "text": "不需治療可自癒" }
    ],
    "answer": "B",
    "explanation": "單純性膀胱炎多可門診口服抗生素治療。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜戊 皮膚與軟組織感染" },
    "stem": "下列何者最符合壞死性筋膜炎的臨床特徵？",
    "options": [
      { "key": "A", "text": "局部紅腫且疼痛程度與外觀不成比例" },
      { "key": "B", "text": "僅有輕微搔癢" },
      { "key": "C", "text": "慢性反覆發作" },
      { "key": "D", "text": "不影響全身狀態" }
    ],
    "answer": "A",
    "explanation": "壞死性筋膜炎常見「疼痛與外觀不成比例」，需緊急手術與廣效抗生素。"
  },


  {
    "id": "MED3_RENAL_INF_DER_SEPSIS_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症｜初期處置" },
    "stem": "懷疑敗血症（sepsis）時，下列哪一項最符合「第一時間處置」的優先順序？",
    "options": [
      { "key": "A", "text": "先等血液培養結果再給抗生素" },
      { "key": "B", "text": "先做完整影像學檢查再開始治療" },
      { "key": "C", "text": "同時抽培養並盡早給予經驗性抗生素與液體復甦" },
      { "key": "D", "text": "只有發燒才需要抗生素" }
    ],
    "answer": "C",
    "explanation": "敗血症的關鍵是「及早復甦＋及早抗生素＋同時做培養」。等待培養或延後治療會增加死亡風險；影像可協助找感染源但不應延誤初始治療。"
  },
  {
    "id": "MED3_RENAL_INF_DER_SEPSIS_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜甲 發燒與敗血症｜敗血性休克" },
    "stem": "下列哪一項最符合敗血性休克（septic shock）的臨床概念？",
    "options": [
      { "key": "A", "text": "任何血液培養陽性皆為 septic shock" },
      { "key": "B", "text": "感染造成器官功能障礙，但血壓可維持" },
      { "key": "C", "text": "感染合併循環衰竭，充分補液後仍需升壓劑維持灌流" },
      { "key": "D", "text": "只有發燒與白血球上升" }
    ],
    "answer": "C",
    "explanation": "Sepsis 是感染合併器官功能障礙；septic shock 是更嚴重的循環/代謝異常狀態，通常需要升壓劑（在充分補液後）以維持灌流壓。"
  },

  {
    "id": "MED3_RENAL_INF_DER_ABX_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜乙 抗生素原則｜降階" },
    "stem": "經驗性廣效抗生素治療後，培養結果回報單一敏感菌株且臨床穩定。最符合抗生素 stewardship 的下一步為何？",
    "options": [
      { "key": "A", "text": "維持原廣效抗生素直到療程結束" },
      { "key": "B", "text": "立即停用所有抗生素" },
      { "key": "C", "text": "依藥敏結果進行降階（de-escalation）到窄效治療" },
      { "key": "D", "text": "改用更廣效抗生素避免復發" }
    ],
    "answer": "C",
    "explanation": "降階可降低抗藥性壓力與藥物不良反應，且在培養與臨床資訊支持下通常不降低療效。"
  },
  {
    "id": "MED3_RENAL_INF_DER_ABX_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜乙 抗生素原則｜腎功能" },
    "stem": "下列何者最正確描述「CKD 病人使用抗生素」的安全原則？",
    "options": [
      { "key": "A", "text": "只要不是 aminoglycoside 就不需調整劑量" },
      { "key": "B", "text": "多數需腎排除藥物應依 eGFR 調整劑量或給藥間隔" },
      { "key": "C", "text": "腎功能越差應使用越高劑量" },
      { "key": "D", "text": "腎功能不影響藥物蓄積" }
    ],
    "answer": "B",
    "explanation": "CKD 會降低多數腎排除抗生素清除率，需依 eGFR 調整劑量/間隔，以避免蓄積毒性與不必要的腎損傷。"
  },

  {
    "id": "MED3_RENAL_INF_DER_PNA_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎｜CAP vs HAP" },
    "stem": "住院第 3 天出現新發咳嗽、發燒與肺浸潤影，最符合哪一種肺炎分類？",
    "options": [
      { "key": "A", "text": "社區型肺炎（CAP）" },
      { "key": "B", "text": "院內型肺炎（HAP）" },
      { "key": "C", "text": "吸入性肺炎（aspiration pneumonia）一定是" },
      { "key": "D", "text": "以上皆非" }
    ],
    "answer": "B",
    "explanation": "HAP 通常定義為住院 ≥48 小時後發生的肺炎。分類重點在時序與抗藥性風險，吸入性是病理機轉之一，不能單靠分類等同。"
  },
  {
    "id": "MED3_RENAL_INF_DER_PNA_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丙 肺炎｜非典型菌" },
    "stem": "社區型肺炎若要涵蓋「非典型致病菌（atypical pathogens）」的經驗性治療考量，下列哪一類藥物最常用於涵蓋？",
    "options": [
      { "key": "A", "text": "β-lactam 單用即可" },
      { "key": "B", "text": "Macrolide 或 doxycycline（或呼吸道 fluoroquinolone）" },
      { "key": "C", "text": "抗黴菌藥" },
      { "key": "D", "text": "抗病毒藥單用" }
    ],
    "answer": "B",
    "explanation": "非典型菌（如 Mycoplasma、Chlamydophila、Legionella）缺乏典型細胞壁結構或表現不同，常需 macrolide/doxycycline 或呼吸道 FQ 來涵蓋；β-lactam 單用不一定涵蓋。"
  },

  {
    "id": "MED3_RENAL_INF_DER_UTI_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜上 vs 下" },
    "stem": "下列哪一項臨床表現最支持「腎盂腎炎（pyelonephritis）」而非單純膀胱炎？",
    "options": [
      { "key": "A", "text": "頻尿、急尿" },
      { "key": "B", "text": "排尿灼熱感" },
      { "key": "C", "text": "發燒合併肋脊角叩擊痛（CVA tenderness）" },
      { "key": "D", "text": "尿液混濁" }
    ],
    "answer": "C",
    "explanation": "腎盂腎炎屬上泌尿道感染，常見全身症狀（發燒、寒顫）與 CVA tenderness；膀胱炎多為下泌尿道症狀為主。"
  },
  {
    "id": "MED3_RENAL_INF_DER_UTI_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜複雜性" },
    "stem": "下列哪一項最符合「複雜性 UTI」的概念（通常需要更完整評估與療程）？",
    "options": [
      { "key": "A", "text": "健康非孕女性單純膀胱炎" },
      { "key": "B", "text": "男性 UTI 或合併尿路結構異常/導尿管" },
      { "key": "C", "text": "只有尿液培養陰性" },
      { "key": "D", "text": "症狀輕微即可視為單純" }
    ],
    "answer": "B",
    "explanation": "男性、孕婦、免疫低下、尿路阻塞/結構異常或導尿管相關感染常視為複雜性 UTI，抗藥性與併發症風險較高。"
  },

  {
    "id": "MED3_RENAL_INF_DER_SSTI_Q0001",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜戊 皮膚軟組織感染｜壞死性筋膜炎" },
    "stem": "懷疑壞死性筋膜炎時，下列哪一項處置最符合「救命關鍵」？",
    "options": [
      { "key": "A", "text": "先口服抗生素觀察 48 小時" },
      { "key": "B", "text": "等待影像學確診後才處理" },
      { "key": "C", "text": "緊急外科評估與手術清創，並合併廣效抗生素" },
      { "key": "D", "text": "只要退燒即可" }
    ],
    "answer": "C",
    "explanation": "壞死性筋膜炎進展快、致死率高，治療核心是及早手術清創＋廣效抗生素；影像可輔助但不能延誤手術時機。"
  },
  {
    "id": "MED3_RENAL_INF_DER_SSTI_Q0002",
    "source_type": "derived",
    "book": { "code": "MED_03_RENAL_INF" },
    "location": { "section": "第二篇 感染科｜戊 皮膚軟組織感染｜蜂窩組織炎 vs 膿瘍" },
    "stem": "皮膚軟組織感染中，若臨床上懷疑「膿瘍（abscess）」形成，下列哪一項原則最正確？",
    "options": [
      { "key": "A", "text": "只要抗生素即可，不需處置" },
      { "key": "B", "text": "切開引流（I&D）常是治療核心，必要時再合併抗生素" },
      { "key": "C", "text": "一定要先做 MRI 才能治療" },
      { "key": "D", "text": "膿瘍與蜂窩組織炎處置完全相同" }
    ],
    "answer": "B",
    "explanation": "膿瘍的關鍵是排膿（I&D）；抗生素是輔助，依嚴重度、全身症狀或高風險族群決定是否加用。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列那一種藥物或狀況最不可能造成呼吸性鹼中毒？",
    "options": [
      { "key": "A", "text": "水楊酸鹽（salicylates）" },
      { "key": "B", "text": "高山" },
      { "key": "C", "text": "懷孕" },
      { "key": "D", "text": "嗎啡（morphine）" }
    ],
    "answer": "D",
    "explanation": "呼吸性鹼中毒多由過度換氣造成（如高山、懷孕、早期水楊酸鹽刺激呼吸中樞）。嗎啡會抑制呼吸、導致 CO2 retention，較可能造成呼吸性酸中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "56 歲男性糖尿病人，Cr 2.0 mg/dL、K+ 5.8、Na+ 139、Cl− 116、HCO3− 18，尿滲透壓高，最可能的診斷為何？",
    "options": [
      { "key": "A", "text": "第二型腎小管酸血症（type 2 RTA）" },
      { "key": "B", "text": "Metformin 引發酸血症（metformin related acidosis）" },
      { "key": "C", "text": "低腎素低醛固酮血症（hyporeninemic hypoaldosteronism）" },
      { "key": "D", "text": "糖尿病酮酸血症（DKA）" }
    ],
    "answer": "C",
    "explanation": "糖尿病相關的低腎素低醛固酮血症屬於 type 4 RTA，典型為高血鉀合併非陰離子間隙代謝性酸中毒（HCO3− 下降）。DKA 通常為高陰離子間隙代謝酸且常伴酮體；type 2 RTA 常見低血鉀。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "35 歲女性因最近血壓升高就診，檢查多數正常但血清 K+ 2.5 mmol/L。下列哪一個診斷最不可能考慮？",
    "options": [
      { "key": "A", "text": "單側腎動脈狹窄（unilateral renal artery stenosis）" },
      { "key": "B", "text": "服用甘草（licorice）" },
      { "key": "C", "text": "Gordon 症候群（Gordon syndrome）" },
      { "key": "D", "text": "原發性皮質醛固酮症（primary aldosteronism）" }
    ],
    "answer": "C",
    "explanation": "低血鉀合併高血壓常見於高醛固酮或類醛固酮狀態（原發性醛固酮症、腎動脈狹窄造成 RAAS 活化、甘草造成 apparent mineralocorticoid excess）。Gordon syndrome（pseudohypoaldosteronism type 2）典型為高血壓合併高血鉀與高氯性代謝性酸中毒，與本題低血鉀不符。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "65 歲男性嘔吐兩天、血壓 85/50、ABG pH 7.49、PaCO2 47、HCO3− 32。下列對此病人的敘述何者最正確？",
    "options": [
      { "key": "A", "text": "血清滲透壓應該 > 310 mOsm/kg H2O" },
      { "key": "B", "text": "尿液鉀離子應該 < 10 mmol/L" },
      { "key": "C", "text": "尿液滲透壓應該 > 500 mOsm/kg H2O" },
      { "key": "D", "text": "尿液氯離子應該 > 20 mmol/L" }
    ],
    "answer": "C",
    "explanation": "嘔吐與容量不足常見代謝性鹼中毒，且因脫水尿液會濃縮（尿滲透壓上升）。容量不足時血清滲透壓不一定升高；代謝性鹼中毒常促進尿鉀流失（不一定低）；嘔吐造成的 chloride-depletion metabolic alkalosis 通常尿 Cl− 低（chloride responsive），不會 >20。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列哪一個病例較符合下列 ABG/電解質：pH 7.32、PaCO2 33、HCO3− 18、Na+ 138、Cl− 109？",
    "options": [
      { "key": "A", "text": "第一型糖尿病熬夜兩天忘記打胰島素" },
      { "key": "B", "text": "服用作用於遠端腎小管之利尿劑減重" },
      { "key": "C", "text": "第五期慢性腎臟病" },
      { "key": "D", "text": "腹瀉三天" }
    ],
    "answer": "D",
    "explanation": "此為代謝性酸中毒且陰離子間隙不高（non-anion gap metabolic acidosis），常見原因為 HCO3− 流失（如腹瀉）或 RTA。DKA/末期腎衰竭較偏高陰離子間隙代謝酸；多數利尿劑（loop/thiazide）傾向代謝性鹼中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "血陰離子隙（anion gap）主要反應下列何項離子的多寡？",
    "options": [
      { "key": "A", "text": "未測量之陽離子（unmeasured cations）" },
      { "key": "B", "text": "鈉離子＋鉀離子（Na+ + K+）" },
      { "key": "C", "text": "未測量之陰離子（unmeasured anions）" },
      { "key": "D", "text": "重碳酸離子＋氯離子（HCO3− + Cl−）" }
    ],
    "answer": "C",
    "explanation": "anion gap 概念上代表「未測量陰離子 − 未測量陽離子」。臨床上當乳酸、酮酸、毒物代謝物等未測量陰離子增加時，anion gap 上升。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列哪一個病例最不符合：pH 7.49、PaCO2 43、HCO3− 28、Na+ 139、K+ 3.0、Cl− 89？",
    "options": [
      { "key": "A", "text": "長期使用利尿劑" },
      { "key": "B", "text": "急性腹瀉三天" },
      { "key": "C", "text": "原發性皮質醛固酮症" },
      { "key": "D", "text": "噁心嘔吐兩天" }
    ],
    "answer": "B",
    "explanation": "此組數據為代謝性鹼中毒（HCO3− 上升）且呈低氯低鉀的型態。利尿劑、嘔吐、醛固酮過多皆可造成代謝性鹼中毒；腹瀉典型是 HCO3− 流失造成 non-anion gap 代謝性酸中毒。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "病人 ABG：pH 7.51、PaCO2 49 mmHg、HCO3− 38 mmol/L。下列何者正確？",
    "options": [
      { "key": "A", "text": "代謝性酸中毒" },
      { "key": "B", "text": "代謝性鹼中毒" },
      { "key": "C", "text": "呼吸性酸中毒" },
      { "key": "D", "text": "呼吸性鹼中毒" }
    ],
    "answer": "B",
    "explanation": "pH 偏鹼且 HCO3− 明顯上升，符合代謝性鹼中毒；PaCO2 上升可視為代償性通氣下降。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "承上題（pH 7.49、PaCO2 43、HCO3− 28、Na+ 139、K+ 3.0、Cl− 89），下列哪一個病例不符合該檢查結果？",
    "options": [
      { "key": "A", "text": "高血壓、間歇性下肢無力，醛固酮濃度升高（原發性醛固酮相關）" },
      { "key": "B", "text": "Sjogren syndrome，腎盂鈣化跡象（考慮 RTA）" },
      { "key": "C", "text": "急性胰臟炎住院，鼻胃管引流每日約 3000 mL" },
      { "key": "D", "text": "長期服用 thiazide diuretics 減肥" }
    ],
    "answer": "B",
    "explanation": "此題檢驗組合偏代謝性鹼中毒；A（醛固酮過多）、C（胃酸流失）、D（thiazide）均可造成代謝性鹼中毒。Sjogren syndrome 相關的遠端（type 1）RTA 則更典型為 non-anion gap 代謝性酸中毒，與題幹不符。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "承上題，若尿液氯離子濃度為 10 mmol/L，何者最符合此結果？",
    "options": [
      { "key": "A", "text": "甲病人（原發性醛固酮相關）" },
      { "key": "B", "text": "乙病人（Sjogren/RTA）" },
      { "key": "C", "text": "丙病人（鼻胃管引流大量胃液）" },
      { "key": "D", "text": "丁病人（持續使用 thiazide）" }
    ],
    "answer": "C",
    "explanation": "尿 Cl− < 20 mmol/L 支持 chloride-responsive metabolic alkalosis（如嘔吐/胃液流失、鼻胃管引流），補生理食鹽水可改善。原發性醛固酮與持續利尿劑使用多屬 chloride-resistant（尿 Cl− 常較高）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列何者不是高陰離子間隙代謝性酸中毒（high anion gap metabolic acidosis）的原因？",
    "options": [
      { "key": "A", "text": "Lactic acidosis" },
      { "key": "B", "text": "Ketoacidosis" },
      { "key": "C", "text": "Diarrhea（腹瀉）" },
      { "key": "D", "text": "Salicylate intoxication" }
    ],
    "answer": "C",
    "explanation": "高陰離子間隙代謝酸常見可用 Lactic、Keto、Toxins/Drugs、Renal failure 來記；腹瀉多為 HCO3− 流失造成 non-anion gap（高氯性）代謝酸。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_ACIDBASE_Q0012",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜甲 酸鹼平衡" },
    "stem": "下列有關低腎素醛固酮分泌不足症（hyporeninemic hypoaldosteronism）的特徵敘述，何者正確？",
    "options": [
      { "key": "A", "text": "代謝性鹼中毒和高鉀血症" },
      { "key": "B", "text": "代謝性酸中毒和高鉀血症" },
      { "key": "C", "text": "代謝性鹼中毒和低鉀血症" },
      { "key": "D", "text": "代謝性酸中毒和低鈉血症" }
    ],
    "answer": "B",
    "explanation": "醛固酮作用為留鈉、排鉀、排酸；低腎素低醛固酮狀態會造成鉀與酸排不出去，典型呈現高血鉀合併代謝性酸中毒（type 4 RTA）。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "一位 40 歲女病人意識障礙，血中鈉離子 115 mmol/L，pH 7.40。下列關於該病人的敘述，何者錯誤？",
    "options": [
      { "key": "A", "text": "該病人的低血鈉症屬於嚴重（severe）" },
      { "key": "B", "text": "緊急處置必須包含靜脈滴注 3% sodium chloride（hypertonic saline）" },
      { "key": "C", "text": "用高濃度食鹽水靜脈輸注時應每 2 小時監測血清鈉濃度並調整輸注" },
      { "key": "D", "text": "補充血中鈉離子時，其上升速度不可超過 12–15 mmol/L/day" }
    ],
    "answer": "D",
    "explanation": "嚴重低血鈉合併神經症狀需以 3% 高張食鹽水緊急處置並密切監測。校正速度一般建議不超過約 10–12 mmol/L/day；若有高風險（如慢性低血鈉、營養不良、肝病、酒精使用等），常建議更保守（例如 ≤8 mmol/L/day），以避免滲透性脫髓鞘症候群。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "75 歲女性主訴最近 1 個月食慾不振與全身虛弱。過去病史：高血壓、糖尿病。身體檢查：意識清楚，血壓 110/70 mmHg，心跳 76/min，無水腫，黏膜乾。Na 117 mmol/L，K 3.5 mmol/L，BUN 30 mg/dL，Cr 1.0 mg/dL。下列敘述何者最不適當？",
    "options": [
      { "key": "A", "text": "病人可能為低容積型低血鈉（hypovolemic hyponatremia）" },
      { "key": "B", "text": "病人應該限制水分攝取" },
      { "key": "C", "text": "緊急處置必須包含靜脈滴注 3% hypertonic saline" },
      { "key": "D", "text": "治療應包含靜脈滴注 0.9% sodium chloride（normal saline）" }
    ],
    "answer": "C",
    "explanation": "此例更像慢性、相對穩定且偏低容積型低血鈉，通常優先矯正體液狀態（如 0.9% NS、停用誘因如利尿劑、評估腎上腺/甲狀腺等），未必需要 3% 高張食鹽水。高張食鹽水主要用於合併中度/重度神經症狀的低血鈉。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "下列關於低血鈉的鑑別診斷，何者最不適當？",
    "options": [
      { "key": "A", "text": "甲狀腺功能低下可能會造成低血鈉" },
      { "key": "B", "text": "利尿劑所造成的腎臟鹽分流失可能造成尿液中鈉濃度高於 20 mM" },
      { "key": "C", "text": "燒傷或腹瀉可能造成尿液中鈉濃度低於 20 mM" },
      { "key": "D", "text": "心衰竭造成的高容積型低血鈉，其尿液中鈉濃度通常大於 20 mM" }
    ],
    "answer": "D",
    "explanation": "心衰竭的高容積型低血鈉通常「有效循環血量下降」→ RAAS 活化 → 腎臟保鈉，因此尿鈉多偏低（常 <20 mM）。尿鈉偏高較符合腎性鹽分流失或 SIADH 等情境。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "Vaptans 可以用於治療哪一種低血鈉症？",
    "options": [
      { "key": "A", "text": "SIADH" },
      { "key": "B", "text": "脫水所造成的低血鈉" },
      { "key": "C", "text": "無症狀的低血鈉" },
      { "key": "D", "text": "伴隨神經症狀的 SIADH" }
    ],
    "answer": "A",
    "explanation": "Vaptans（vasopressin receptor antagonists）主要用於水分排除不當的低血鈉（如 SIADH；亦可見於部分高容積型低血鈉）。伴嚴重神經症狀者多以高張食鹽水急救為先。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_DI_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉/尿崩鑑別" },
    "stem": "一位 20 歲男性有嚴重多尿。禁水 4 小時後小便滲透壓沒有明顯上升；注射 desmopressin 後小便滲透壓亦沒有明顯上升。最可能的診斷為何？",
    "options": [
      { "key": "A", "text": "中樞型尿崩症（central diabetes insipidus）" },
      { "key": "B", "text": "腎性尿崩症（nephrogenic diabetes insipidus）" },
      { "key": "C", "text": "不適當抗利尿激素症候群（SIADH）" },
      { "key": "D", "text": "心因性多飲（psychogenic polydipsia）" }
    ],
    "answer": "B",
    "explanation": "禁水後尿滲透壓未上升代表無法濃縮尿；給予 desmopressin 仍無反應更支持腎臟對 ADH 不敏感（腎性尿崩症），而非中樞型尿崩症。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "56 歲男性腎病症候群，血液 osmolality 255 mOsm/kg、Na 120 mmol/L。下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "病人的細胞外液（ECF）容積增加" },
      { "key": "B", "text": "病人的細胞內液（ICF）容積增加" },
      { "key": "C", "text": "病人的有效循環血量（effective blood volume）增加" },
      { "key": "D", "text": "病人的有效循環血量（effective blood volume）下降" }
    ],
    "answer": "C",
    "explanation": "腎病症候群可見水腫（ECF 增加），且低滲狀態水分可進入細胞（ICF 增加）；但因膠體滲透壓下降與有效循環血量下降而促進保水保鈉，因此 effective blood volume 下降較符合。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "下列有關低血鈉症的描述，何者正確？",
    "options": [
      { "key": "A", "text": "如果血漿滲透壓低，應該考慮是否為高血糖造成的假性低血鈉" },
      { "key": "B", "text": "心衰竭可能造成細胞外液增加與低血鈉症" },
      { "key": "C", "text": "低容積型低血鈉合併尿鈉 <10 mmol/L 表示腎病變造成鈉流失" },
      { "key": "D", "text": "SIADH 的血漿滲透壓通常正常且 ECF 減少" }
    ],
    "answer": "B",
    "explanation": "心衰竭可造成高容積型低血鈉。高血糖造成的低血鈉多是「高滲」情境；低容積且尿鈉很低常見於腎外流失（如腹瀉、嘔吐）；SIADH 通常為低滲、近似正容積（euvolemic）低血鈉。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "下列那一種低血鈉症最適合使用 0.9% sodium chloride（normal saline）治療？",
    "options": [
      { "key": "A", "text": "SIADH" },
      { "key": "B", "text": "心衰竭" },
      { "key": "C", "text": "aldosterone deficiency" },
      { "key": "D", "text": "肝硬化" }
    ],
    "answer": "C",
    "explanation": "等張食鹽水最適合用於低容積型低血鈉（例如腎上腺/醛固酮不足、腎外液體流失等）以回復有效循環血量；SIADH/心衰竭/肝硬化多屬非低容積型，治療策略不同。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "88 歲男性因近乎昏厥送急診。Lab：Na 124 mmol/L、K 3.5 mmol/L、Cl 94 mmol/L、BUN 15.3 mg/dL、Cr 0.92 mg/dL、troponin I <0.012 ng/mL、hsTSH 66.7 μIU/mL。下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "該病人是低血鈉症" },
      { "key": "B", "text": "應評估是否有內分泌原因（如甲狀腺或腎上腺）" },
      { "key": "C", "text": "此案例需將甲狀腺功能異常納入鑑別診斷" },
      { "key": "D", "text": "抽血結果較符合 hyperthyroidism（甲狀腺機能亢進）" }
    ],
    "answer": "D",
    "explanation": "hsTSH 顯著上升更支持甲狀腺機能低下（hypothyroidism），而非甲狀腺機能亢進。甲狀腺機能低下可造成低血鈉，需納入鑑別。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "關於 SIADH（syndrome of inappropriate ADH secretion），下列何者可能是造成低血鈉症的原因？",
    "options": [
      { "key": "A", "text": "Cefazolin (Kefzol)" },
      { "key": "B", "text": "肺部感染" },
      { "key": "C", "text": "E. coli 感染" },
      { "key": "D", "text": "Group B streptococcus 感染" }
    ],
    "answer": "B",
    "explanation": "SIADH 常與肺部病灶/肺炎、CNS 病變、部分腫瘤（如小細胞肺癌）或特定藥物相關；肺部感染是經典誘因之一。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "63 歲男性肺癌病人接受化學治療三天後因意識不清送急診。Vitals：BP 124/75、HR 78、RR 18。Lab：Na 108 mmol/L、K 4.0 mmol/L、Cl 80 mmol/L、HCO3 22 mmol/L、BUN 15 mg/dL、Cr 0.9 mg/dL、serum osmolality 232 mOsm/kg、urine osmolality 450 mOsm/kg、urine Na 45 mmol/L。下列敘述何者正確？",
    "options": [
      { "key": "A", "text": "病人可能為 euvolemic hyponatremia" },
      { "key": "B", "text": "病人可能為 hypovolemic hyponatremia" },
      { "key": "C", "text": "病人可能為 hypervolemic hyponatremia" },
      { "key": "D", "text": "病人可能為 pseudohyponatremia" }
    ],
    "answer": "A",
    "explanation": "低血鈉且低血漿滲透壓，合併尿滲透壓偏高與尿鈉偏高，符合 ADH 不當上升/腎臟未適當排水的型態，最典型為 SIADH；臨床上多呈 euvolemic hyponatremia。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPONa_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜A 低血鈉" },
    "stem": "一名 60 歲婦女因意識不清與倦怠住院。病人有糖尿病，長期服用 metformin。檢查發現血鈉 110 mmol/L、血漿滲透壓 225 mOsm/kg、尿滲透壓 400 mOsm/kg。影像顯示肺部小細胞癌。若太快校正此病人的電解質異常，最擔心發生下列何種併發症？",
    "options": [
      { "key": "A", "text": "反彈性高血糖（rebound hyperglycemia）" },
      { "key": "B", "text": "滲透性大腦去髓鞘症候群（osmotic cerebral demyelination syndrome）" },
      { "key": "C", "text": "反彈性低血鈉（rebound hyponatremia）" },
      { "key": "D", "text": "急性腎衰竭（acute renal failure）" }
    ],
    "answer": "B",
    "explanation": "慢性或長期低血鈉若矯正過快，最重要的致命/致殘風險為滲透性脫髓鞘（中央橋腦溶解等）。因此校正速率需嚴格控制並密切監測。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPERNa_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜B 高血鈉" },
    "stem": "35 歲女性病人意識不清，血中 Na 160 mmol/L。下列處置何者最適當？",
    "options": [
      { "key": "A", "text": "計算 free water deficit 並用 5% dextrose（D5W）緩慢矯正" },
      { "key": "B", "text": "使用 3% hypertonic saline 緊急矯正" },
      { "key": "C", "text": "以 0.9% normal saline 迅速矯正至正常" },
      { "key": "D", "text": "不需處置，觀察即可" }
    ],
    "answer": "A",
    "explanation": "高血鈉代表缺水或自由水相對不足；處置重點是估算自由水缺乏量並以低滲液（如 D5W 或口服/腸道補水）緩慢矯正，避免矯正過快造成腦水腫。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_PHYSIO_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜腎臟生理" },
    "stem": "注射 ADH 後，腎臟哪一處對水的通透度增加最顯著？",
    "options": [
      { "key": "A", "text": "Proximal convoluted tubule" },
      { "key": "B", "text": "Ascending limb of the loop of Henle" },
      { "key": "C", "text": "Distal tubule" },
      { "key": "D", "text": "Collecting duct" }
    ],
    "answer": "D",
    "explanation": "ADH 主要增加集合管（尤其皮質/髓質集合管）主細胞的水通道（AQP2）插入，顯著提升水通透度；晚期遠曲小管亦可受影響，但臨床與考題多以 collecting duct 為主。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPERK_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜D 高血鉀" },
    "stem": "下列何者最不會導致高血鉀（hyperkalemia）的發生？",
    "options": [
      { "key": "A", "text": "Excessive intake of potassium" },
      { "key": "B", "text": "Potassium-sparing diuretics" },
      { "key": "C", "text": "Angiotensin-converting enzyme inhibitors" },
      { "key": "D", "text": "NSAIDs (nonsteroidal anti-inflammatory drugs)" }
    ],
    "answer": "A",
    "explanation": "單純高鉀攝取在腎功能正常者通常可由腎臟排除，不一定造成高血鉀；相對地，保鉀利尿劑、ACEi、NSAIDs（抑制腎素/醛固酮軸）均可降低排鉀能力而導致高血鉀。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPERK_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜腎小管細胞" },
    "stem": "Cortical collecting duct cells 中，哪一種細胞負責 reabsorb sodium？",
    "options": [
      { "key": "A", "text": "Principal cells" },
      { "key": "B", "text": "Type A intercalated cells" },
      { "key": "C", "text": "Type B intercalated cells" },
      { "key": "D", "text": "Macula densa cells" }
    ],
    "answer": "A",
    "explanation": "集合管 principal cells 主要負責鈉再吸收（ENaC）與鉀分泌；Type A/B intercalated cells 主要與酸鹼調節相關。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPOK_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
    "stem": "關於低血鉀症（hypokalemia），下列敘述何者最不適當？",
    "options": [
      { "key": "A", "text": "會造成 muscle weakness" },
      { "key": "B", "text": "會使 PR interval prolonged" },
      { "key": "C", "text": "會增加 T wave amplitude" },
      { "key": "D", "text": "會導致 cardiac arrhythmia" }
    ],
    "answer": "C",
    "explanation": "低血鉀常見心電圖變化包含 T wave 變平、U wave、ST depression、QT 延長與心律不整風險上升；不會造成 T wave amplitude 增加。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPOK_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
    "stem": "80 歲女性低血鉀（K 2.5 mmol/L），血液 pH 7.50、HCO3 35 mEq/L。下列處置何者最不適當？",
    "options": [
      { "key": "A", "text": "給予 potassium chloride 補充" },
      { "key": "B", "text": "停用可能導致低血鉀的利尿劑並評估病因" },
      { "key": "C", "text": "以 5% dextrose（葡萄糖水）作為補鉀輸液的溶媒" },
      { "key": "D", "text": "測定血清鎂離子並於需要時補充鎂" }
    ],
    "answer": "C",
    "explanation": "葡萄糖輸注會促進胰島素分泌，使鉀離子移入細胞，可能惡化低血鉀；補鉀通常避免使用含葡萄糖溶液作為主要溶媒（除非有特殊情境並嚴密監測）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_IONBAL_HYPOK_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜乙 離子平衡｜C 低血鉀" },
    "stem": "25 歲男性下肢無力至急診。K 2.0 mmol/L、pH 7.40、HCO3 24 mmol/L、磷 1.8 mg/dL、尿鉀 10 mmol/L、尿滲透壓 580 mOsm/kg、無服用利尿劑。下列何者最適當？",
    "options": [
      { "key": "A", "text": "立刻停止葡萄糖輸液避免低血鉀惡化" },
      { "key": "B", "text": "以周邊靜脈快速給予 KCl 10–20 mEq/hr 並不需進一步評估" },
      { "key": "C", "text": "加驗甲狀腺功能以評估甲狀腺毒性週期性麻痺（thyrotoxic periodic paralysis）" },
      { "key": "D", "text": "計算 TTKG 以確診腎性鉀流失為主因" }
    ],
    "answer": "C",
    "explanation": "年輕男性、急性麻痺、低血鉀合併低血磷且尿鉀不高，較像鉀移入細胞（shift）型低血鉀；典型鑑別為甲狀腺毒性週期性麻痺，應加驗甲狀腺功能並同時謹慎補鉀、治療誘因。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "依 KDIGO 定義，下列何者符合急性腎損傷（AKI）診斷？",
    "options": [
      { "key": "A", "text": "血清 creatinine 於 48 小時內上升 ≥0.3 mg/dL" },
      { "key": "B", "text": "eGFR 下降但持續不到 1 週" },
      { "key": "C", "text": "血清 creatinine 於 1 個月內上升 10%" },
      { "key": "D", "text": "任何一次 creatinine 高於正常上限" }
    ],
    "answer": "A",
    "explanation": "KDIGO AKI 其中一個診斷標準為 48 小時內 SCr 上升 ≥0.3 mg/dL（或 7 天內 ≥1.5 倍基準值，或尿量 <0.5 mL/kg/hr 持續 ≥6 小時）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "腎前性 AKI 最典型的尿液檢查特徵為何？",
    "options": [
      { "key": "A", "text": "尿液鈉濃度高、FENa >2%" },
      { "key": "B", "text": "尿滲透壓偏高、尿鈉偏低" },
      { "key": "C", "text": "尿沈渣大量 RBC casts" },
      { "key": "D", "text": "尿沈渣大量 WBC casts" }
    ],
    "answer": "B",
    "explanation": "腎前性 AKI 因腎小管功能尚可，會強烈保鈉保水：尿鈉低、尿滲透壓高、FENa 多 <1%。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "懷疑腎後性（postrenal）AKI 時，最實用的第一線影像檢查為何？",
    "options": [
      { "key": "A", "text": "腎臟超音波（評估 hydronephrosis）" },
      { "key": "B", "text": "腎臟 MRI" },
      { "key": "C", "text": "腎臟穿刺切片" },
      { "key": "D", "text": "腎臟核醫掃描" }
    ],
    "answer": "A",
    "explanation": "腎後性 AKI 先找阻塞：腎臟超音波可快速評估是否有腎盂腎盞擴張（hydronephrosis），臨床最常用也最安全。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "下列何者最符合急性間質性腎炎（acute interstitial nephritis, AIN）的典型線索？",
    "options": [
      { "key": "A", "text": "泥沙樣圓柱（muddy brown casts）" },
      { "key": "B", "text": "發燒、皮疹、嗜酸性球上升（可出現）" },
      { "key": "C", "text": "大量蛋白尿 >3.5 g/day" },
      { "key": "D", "text": "嚴重低補體血症為最典型" }
    ],
    "answer": "B",
    "explanation": "AIN 常與藥物/感染相關，典型提示可見發燒、皮疹、嗜酸性球上升（不一定三者俱全），尿液可見白血球、白血球圓柱；A 更像 ATN。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "疑似橫紋肌溶解（rhabdomyolysis）導致 AKI 時，尿液 dipstick 與尿沈渣的典型組合為何？",
    "options": [
      { "key": "A", "text": "dipstick 血尿陰性，尿沈渣大量 RBC" },
      { "key": "B", "text": "dipstick 血尿陽性，但尿沈渣 RBC 很少或沒有" },
      { "key": "C", "text": "dipstick 白血球酯酶陽性，尿沈渣 WBC casts" },
      { "key": "D", "text": "dipstick 蛋白陽性且必定 >3.5 g/day" }
    ],
    "answer": "B",
    "explanation": "myoglobin 會讓 dipstick 呈「heme 陽性」，但顯微鏡下 RBC 不多（或無），合併 CK 大幅升高可支持 rhabdomyolysis。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "預防造影劑相關腎損傷（contrast-associated AKI）最有效且最常用的策略為何？",
    "options": [
      { "key": "A", "text": "常規使用利尿劑促進排尿" },
      { "key": "B", "text": "常規使用 NSAIDs 減少發炎" },
      { "key": "C", "text": "等張液體補充（如 0.9% NS）作為周邊水化" },
      { "key": "D", "text": "給予高張食鹽水快速矯正腎灌流" }
    ],
    "answer": "C",
    "explanation": "高風險病人接受含碘造影前後，最核心的可行策略是等張水化（IV isotonic fluids），並同時避免腎毒性藥物與控制造影劑劑量。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "AKI 需緊急透析的適應症（AEIOU）中，下列何者最符合 “E” 的意義？",
    "options": [
      { "key": "A", "text": "Encephalopathy（尿毒性腦病變）" },
      { "key": "B", "text": "Edema（難以控制的肺水腫/容量負荷）" },
      { "key": "C", "text": "Elevated creatinine（肌酸酐升高）" },
      { "key": "D", "text": "Eosinophilia（嗜酸性球上升）" }
    ],
    "answer": "B",
    "explanation": "AEIOU：Acidosis（難以控制酸中毒）、Electrolytes（高鉀等）、Intoxications、Overload（容量負荷/肺水腫）、Uremia（尿毒症狀）。其中 “O” 也常寫 Overload；此題以 Edema/Overload 對應。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_AKI_Q0012",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丙 急性腎損傷（AKI）" },
    "stem": "下列何者最支持腎小球來源的血尿（glomerular hematuria）？",
    "options": [
      { "key": "A", "text": "尿沈渣見 dysmorphic RBC 或 RBC casts" },
      { "key": "B", "text": "尿液中 nitrite 陽性" },
      { "key": "C", "text": "尿液中大量結晶" },
      { "key": "D", "text": "尿比重偏低（低滲尿）" }
    ],
    "answer": "A",
    "explanation": "腎小球出血常見變形紅血球（dysmorphic RBC）與 RBC casts；nitrite 更支持細菌性 UTI。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "成人腎病症候群最常見的原發性腎小球疾病為何？",
    "options": [
      { "key": "A", "text": "Minimal change disease" },
      { "key": "B", "text": "Membranous nephropathy" },
      { "key": "C", "text": "Post-streptococcal GN" },
      { "key": "D", "text": "Alport syndrome" }
    ],
    "answer": "B",
    "explanation": "兒童腎病症候群最常見為 minimal change disease；成人則常以 membranous nephropathy 與 FSGS 為主。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "Minimal change disease 最典型的病理/臨床線索為何？",
    "options": [
      { "key": "A", "text": "光顯可見節段性硬化，IF 顯示 IgA 沉積" },
      { "key": "B", "text": "電顯可見足突融合（foot process effacement），對類固醇反應佳" },
      { "key": "C", "text": "光顯可見明顯增生伴新月體形成" },
      { "key": "D", "text": "與 HBV/HCV 最相關，常合併低補體" }
    ],
    "answer": "B",
    "explanation": "Minimal change disease 的核心是 podocyte injury，電顯足突融合最典型，臨床上對類固醇治療反應佳。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "Membranous nephropathy 最典型的免疫螢光（IF）型態為何？",
    "options": [
      { "key": "A", "text": "線狀（linear）沉積沿 GBM" },
      { "key": "B", "text": "顆粒狀（granular）沉積沿 GBM" },
      { "key": "C", "text": "僅在系膜（mesangium）IgA 沉積" },
      { "key": "D", "text": "完全無免疫沉積（pauci-immune）" }
    ],
    "answer": "B",
    "explanation": "Membranous nephropathy 為免疫複合體沉積型腎小球病變，典型 IF 為沿 GBM 顆粒狀 IgG/C3 沉積。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群" },
    "stem": "下列何者最符合 diabetic nephropathy 的臨床自然史？",
    "options": [
      { "key": "A", "text": "突然肉眼血尿、補體下降、腎功能急速惡化" },
      { "key": "B", "text": "先出現 microalbuminuria，之後進展至蛋白尿與 eGFR 下降" },
      { "key": "C", "text": "典型為反覆上呼吸道感染後 1–2 天血尿" },
      { "key": "D", "text": "多為 isolated hematuria，蛋白尿很少見" }
    ],
    "answer": "B",
    "explanation": "糖尿病腎病變常先由微量白蛋白尿開始，之後進展到顯性蛋白尿並逐步腎功能下降。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎炎症候群" },
    "stem": "急性鏈球菌感染後腎炎（PSGN）最典型的補體變化為何？",
    "options": [
      { "key": "A", "text": "C3 下降且 C4 下降" },
      { "key": "B", "text": "C3 下降、C4 通常正常" },
      { "key": "C", "text": "C3 正常、C4 下降" },
      { "key": "D", "text": "C3 與 C4 都正常" }
    ],
    "answer": "B",
    "explanation": "PSGN 常見替代路徑活化，典型表現為低 C3、C4 多正常，並會在數週內逐漸恢復。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎炎症候群" },
    "stem": "IgA 腎病變與 PSGN 的鑑別重點之一是血尿出現的時序。下列何者正確？",
    "options": [
      { "key": "A", "text": "IgA 腎病變多在感染後 1–2 天內出現血尿" },
      { "key": "B", "text": "IgA 腎病變多在感染後 2–3 週出現血尿" },
      { "key": "C", "text": "PSGN 多在感染後 1–2 天內出現血尿" },
      { "key": "D", "text": "兩者皆與感染無關" }
    ],
    "answer": "A",
    "explanation": "IgA 腎病變常見「synpharyngitic hematuria」：上呼吸道感染後很短時間（1–2 天）血尿；PSGN 則多在 1–3 週後。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜快速進行性腎小球腎炎（RPGN）" },
    "stem": "RPGN 的病理最具代表性的描述為何？",
    "options": [
      { "key": "A", "text": "腎小管上皮壞死為主" },
      { "key": "B", "text": "腎小球新月體（crescents）形成" },
      { "key": "C", "text": "腎小球基底膜均勻變厚且無增生" },
      { "key": "D", "text": "腎間質大量脂肪沉積" }
    ],
    "answer": "B",
    "explanation": "RPGN 的經典病理為腎小球新月體形成，代表嚴重腎小球發炎/破壞，臨床多呈快速腎功能惡化。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜快速進行性腎小球腎炎（RPGN）" },
    "stem": "Goodpasture syndrome（anti-GBM disease）最典型的 IF 表現為何？",
    "options": [
      { "key": "A", "text": "顆粒狀（granular）IgG 沿 GBM" },
      { "key": "B", "text": "線狀（linear）IgG 沿 GBM" },
      { "key": "C", "text": "僅系膜 IgA 沉積" },
      { "key": "D", "text": "無免疫沉積（pauci-immune）" }
    ],
    "answer": "B",
    "explanation": "anti-GBM disease 的特色為抗體直接針對 GBM，IF 典型呈線狀（linear）IgG 沉積。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜快速進行性腎小球腎炎（RPGN）" },
    "stem": "ANCA-associated vasculitis 造成的腎炎在腎切片免疫螢光上最典型的特徵為何？",
    "options": [
      { "key": "A", "text": "線狀 IgG 沉積" },
      { "key": "B", "text": "顆粒狀 IgG/C3 沉積" },
      { "key": "C", "text": "pauci-immune（免疫沉積很少或幾乎沒有）" },
      { "key": "D", "text": "只出現 IgA 沉積" }
    ],
    "answer": "C",
    "explanation": "ANCA 相關血管炎的腎炎通常為 pauci-immune crescentic GN：免疫沉積少，但發炎破壞嚴重、可見新月體。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜次發性腎小球疾病" },
    "stem": "下列哪一種情境最符合 membranous nephropathy 的重要次發性原因之一？",
    "options": [
      { "key": "A", "text": "Hepatitis B / malignancy（如實體腫瘤）" },
      { "key": "B", "text": "急性腸胃炎造成脫水" },
      { "key": "C", "text": "腎結石造成血尿" },
      { "key": "D", "text": "心因性多飲" }
    ],
    "answer": "A",
    "explanation": "Membranous nephropathy 可為原發或次發；次發性常與惡性腫瘤、HBV、部分自體免疫疾病或藥物相關。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0011",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜次發性腎小球疾病" },
    "stem": "Lupus nephritis 常見的免疫學線索中，下列何者最典型？",
    "options": [
      { "key": "A", "text": "anti-GBM 抗體陽性、IF 呈線狀 IgG" },
      { "key": "B", "text": "ANA/anti-dsDNA 相關，且常見低補體" },
      { "key": "C", "text": "只會造成 isolated hematuria，蛋白尿罕見" },
      { "key": "D", "text": "尿鈉 <10 mmol/L 為診斷關鍵" }
    ],
    "answer": "B",
    "explanation": "狼瘡腎炎常與 ANA、anti-dsDNA 上升及補體消耗（C3/C4 下降）相關，臨床可表現蛋白尿、血尿與腎功能異常。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_GN_Q0012",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜丁 腎臟疾病各論｜腎病症候群併發症" },
    "stem": "腎病症候群常見併發症，下列何者最正確？",
    "options": [
      { "key": "A", "text": "出血傾向增加，最擔心顱內出血" },
      { "key": "B", "text": "血栓風險增加，特別是腎靜脈栓塞" },
      { "key": "C", "text": "白血球大量上升是典型" },
      { "key": "D", "text": "必定出現高鈣血症" }
    ],
    "answer": "B",
    "explanation": "腎病症候群因抗凝因子（如 antithrombin III）流失與高凝狀態，血栓風險上升；腎靜脈栓塞是典型考點之一。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "下列何者不是急性透析的典型適應症（AEIOU）？",
    "options": [
      { "key": "A", "text": "難以控制的代謝性酸中毒" },
      { "key": "B", "text": "高血鉀合併心電圖變化" },
      { "key": "C", "text": "血肌酸酐上升但無症狀" },
      { "key": "D", "text": "容量負荷導致肺水腫且對利尿劑反應差" }
    ],
    "answer": "C",
    "explanation": "透析是因「併發症/症狀」與無法控制的代謝/容量問題，而非單看 creatinine 數值。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "下列何者最適合做為長期血液透析（HD）的血管通路？",
    "options": [
      { "key": "A", "text": "周邊靜脈留置針" },
      { "key": "B", "text": "動靜脈瘻管（AV fistula）" },
      { "key": "C", "text": "短期未隧道化中心靜脈導管" },
      { "key": "D", "text": "腹膜透析導管" }
    ],
    "answer": "B",
    "explanation": "長期 HD 首選 AV fistula（感染與血栓風險較低、壽命較長）；中心靜脈導管多作為短期或橋接。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "透析失衡症候群（dialysis disequilibrium syndrome）最典型的情境為何？",
    "options": [
      { "key": "A", "text": "長期規則透析病人，每次透析後" },
      { "key": "B", "text": "初次或久未透析、BUN 很高者接受快速透析後" },
      { "key": "C", "text": "腹膜透析病人使用高糖透析液後" },
      { "key": "D", "text": "腎移植後使用 tacrolimus 期間" }
    ],
    "answer": "B",
    "explanation": "高尿素血症病人若快速清除溶質，易造成腦內外滲透壓差→腦水腫，出現頭痛、噁心、抽搐、意識改變。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "腹膜透析（PD）最常見且最重要的急性併發症為何？",
    "options": [
      { "key": "A", "text": "腦出血" },
      { "key": "B", "text": "腹膜炎（peritonitis）" },
      { "key": "C", "text": "致命性心律不整" },
      { "key": "D", "text": "高血糖一定發生" }
    ],
    "answer": "B",
    "explanation": "PD 主要急症為腹膜炎，典型為腹痛、混濁透析液、發燒，需立即評估與抗生素治療。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_DIALYSIS_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜戊 透析（Dialysis）" },
    "stem": "關於腹膜透析（PD）的溶質清除原理，下列何者最正確？",
    "options": [
      { "key": "A", "text": "主要靠對流（convection）" },
      { "key": "B", "text": "主要靠擴散（diffusion），超濾靠滲透壓梯度" },
      { "key": "C", "text": "主要靠腎小球濾過" },
      { "key": "D", "text": "主要靠腎小管分泌" }
    ],
    "answer": "B",
    "explanation": "PD 的小分子清除以擴散為主；液體移除（ultrafiltration）則靠透析液葡萄糖等造成的滲透壓梯度。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "腎移植後「超急性排斥（hyperacute rejection）」最常見的機轉為何？",
    "options": [
      { "key": "A", "text": "T cell-mediated delayed hypersensitivity" },
      { "key": "B", "text": "既存抗體（preformed antibodies）造成補體活化與血栓" },
      { "key": "C", "text": "藥物毒性造成腎小管壞死" },
      { "key": "D", "text": "病毒感染造成腎炎" }
    ],
    "answer": "B",
    "explanation": "超急性排斥多因既存 anti-HLA/ABO 抗體，移植後立即引發補體活化、血管內血栓、移植腎快速失敗。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "腎移植後早期（數天到數週）出現 creatinine 上升，超音波無阻塞、血流尚可。下列何者最需要優先考慮？",
    "options": [
      { "key": "A", "text": "急性排斥反應或 CNI（如 tacrolimus）毒性" },
      { "key": "B", "text": "腎細胞癌轉移" },
      { "key": "C", "text": "多囊腎破裂" },
      { "key": "D", "text": "腎結石一定是主因" }
    ],
    "answer": "A",
    "explanation": "移植後早期腎功能惡化的常見鑑別包含急性排斥、CNI 藥物毒性、感染、脫水、血管/尿路併發症等；已排除阻塞與主要血流問題時，排斥/藥毒性要優先想。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "下列何者最典型屬於 calcineurin inhibitor（CNI，例如 cyclosporine/tacrolimus）的副作用？",
    "options": [
      { "key": "A", "text": "腎毒性與高血壓" },
      { "key": "B", "text": "嚴重骨髓抑制為主" },
      { "key": "C", "text": "不可逆的聽力喪失" },
      { "key": "D", "text": "腎結石一定形成" }
    ],
    "answer": "A",
    "explanation": "CNI 常見腎血管收縮導致腎毒性、亦可造成高血壓、神經毒性、電解質異常等。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_TX_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜己 腎臟移植（Transplantation）" },
    "stem": "腎移植後長期免疫抑制最常見的感染風險之一為何？",
    "options": [
      { "key": "A", "text": "CMV 相關感染" },
      { "key": "B", "text": "霍亂" },
      { "key": "C", "text": "破傷風" },
      { "key": "D", "text": "狂犬病" }
    ],
    "answer": "A",
    "explanation": "移植後免疫抑制常增加機會性感染風險，CMV 是常考也常見的重要病原。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "最常見的腎結石成分為何？",
    "options": [
      { "key": "A", "text": "Calcium oxalate" },
      { "key": "B", "text": "Cystine" },
      { "key": "C", "text": "Uric acid" },
      { "key": "D", "text": "Struvite（magnesium ammonium phosphate）" }
    ],
    "answer": "A",
    "explanation": "最常見為鈣結石，以 calcium oxalate 為主。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "下列何者最典型與 struvite stone 相關？",
    "options": [
      { "key": "A", "text": "高草酸飲食" },
      { "key": "B", "text": "urease-producing bacteria 感染" },
      { "key": "C", "text": "低尿酸血症" },
      { "key": "D", "text": "長期低鈣飲食" }
    ],
    "answer": "B",
    "explanation": "struvite stone 與 urease-producing bacteria（如 Proteus、部分 Klebsiella 等）相關，尿液偏鹼性，常形成鹿角狀結石（staghorn calculus）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "下列何者最符合 uric acid stone 的特性？",
    "options": [
      { "key": "A", "text": "尿液偏鹼性、結石多為放射線不透（radiopaque）" },
      { "key": "B", "text": "尿液偏酸性、結石多為放射線透亮（radiolucent）" },
      { "key": "C", "text": "與 urease bacteria 感染最相關" },
      { "key": "D", "text": "一定合併高血鈣" }
    ],
    "answer": "B",
    "explanation": "uric acid stone 常在酸性尿形成，且多為 radiolucent（X 光不易看到，CT 可見）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "腎絞痛合併發燒、疑似阻塞併感染時，下列何者為最重要的處置原則？",
    "options": [
      { "key": "A", "text": "止痛後門診追蹤即可" },
      { "key": "B", "text": "先等結石自然排出再給抗生素" },
      { "key": "C", "text": "緊急引流解除阻塞（stent/PCN）並合併抗生素" },
      { "key": "D", "text": "僅給利尿劑促進排石" }
    ],
    "answer": "C",
    "explanation": "阻塞合併感染是泌尿道敗血症風險情境，關鍵是「引流解除阻塞＋抗生素」，不能只靠止痛或等待排石。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_STONE_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜庚 腎結石（Nephrolithiasis）" },
    "stem": "下列何者最符合 cystine stone 的線索？",
    "options": [
      { "key": "A", "text": "尿液中六角形（hexagonal）結晶" },
      { "key": "B", "text": "尿液偏鹼性且與 urease bacteria 相關" },
      { "key": "C", "text": "與高尿酸血症最相關" },
      { "key": "D", "text": "多見於老年人且與吸菸相關" }
    ],
    "answer": "A",
    "explanation": "cystinuria 的典型尿沉渣為六角形結晶；屬遺傳性胺基酸運輸異常。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_PKD_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜壬 多囊腎（PKD）" },
    "stem": "成人常見的遺傳性多囊腎（ADPKD）最典型的腎外併發症為何？",
    "options": [
      { "key": "A", "text": "甲狀腺癌" },
      { "key": "B", "text": "顱內動脈瘤（berry aneurysm）" },
      { "key": "C", "text": "原發性肺纖維化" },
      { "key": "D", "text": "硬皮症" }
    ],
    "answer": "B",
    "explanation": "ADPKD 重要腎外併發症包含顱內動脈瘤、肝囊腫、二尖瓣脫垂等；其中 berry aneurysm 是高風險考點。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_PKD_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜壬 多囊腎（PKD）" },
    "stem": "ADPKD 病人出現肉眼血尿與側腹痛時，下列何者最需要納入鑑別？",
    "options": [
      { "key": "A", "text": "囊腫出血或感染" },
      { "key": "B", "text": "必定是 PSGN" },
      { "key": "C", "text": "必定是腎移植排斥" },
      { "key": "D", "text": "一定是藥物性 AIN" }
    ],
    "answer": "A",
    "explanation": "ADPKD 常見症狀包含側腹痛、肉眼血尿；常見原因為囊腫出血、囊腫感染或結石等。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_PKD_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜壬 多囊腎（PKD）" },
    "stem": "ADPKD 最常用於篩檢/初步診斷的影像工具為何？",
    "options": [
      { "key": "A", "text": "腎臟超音波" },
      { "key": "B", "text": "腎臟 PET-CT" },
      { "key": "C", "text": "腎臟穿刺切片" },
      { "key": "D", "text": "腎動脈攝影" }
    ],
    "answer": "A",
    "explanation": "腎臟超音波是最常用、方便且無侵入性的初步診斷工具；必要時可用 CT/MRI 進一步評估。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "腎細胞癌（RCC）典型三徵（classic triad）為何？",
    "options": [
      { "key": "A", "text": "咳嗽、咳血、胸痛" },
      { "key": "B", "text": "血尿、側腹痛、可觸及腫塊" },
      { "key": "C", "text": "發燒、黃疸、腹水" },
      { "key": "D", "text": "水腫、蛋白尿、高血脂" }
    ],
    "answer": "B",
    "explanation": "RCC 的 classic triad 為血尿、側腹痛、腹部腫塊（但臨床上並不一定三者都出現）。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "下列何者最符合 RCC 的副腫瘤症候群（paraneoplastic syndrome）之一？",
    "options": [
      { "key": "A", "text": "多血症（polycythemia）" },
      { "key": "B", "text": "重度低白蛋白血症必發" },
      { "key": "C", "text": "甲狀腺功能低下必發" },
      { "key": "D", "text": "尿酸一定下降" }
    ],
    "answer": "A",
    "explanation": "RCC 可分泌 EPO 導致多血症，也可能造成高鈣血症（PTHrP）、高血壓（renin）、肝功能異常（Stauffer syndrome）等副腫瘤表現。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "下列何者為 RCC 的重要危險因子？",
    "options": [
      { "key": "A", "text": "吸菸" },
      { "key": "B", "text": "低鹽飲食" },
      { "key": "C", "text": "規則運動" },
      { "key": "D", "text": "高纖飲食" }
    ],
    "answer": "A",
    "explanation": "RCC 重要風險因子包含吸菸、肥胖、高血壓、特定遺傳症候群（如 VHL）等。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_RCC_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第一篇 腎內科｜癸 腎細胞癌（RCC）" },
    "stem": "下列哪一種影像檢查最常用於評估腎腫塊並協助分期（staging）？",
    "options": [
      { "key": "A", "text": "對比增強腹部 CT" },
      { "key": "B", "text": "單純 KUB X-ray" },
      { "key": "C", "text": "腎臟核醫 DMSA" },
      { "key": "D", "text": "胸部超音波" }
    ],
    "answer": "A",
    "explanation": "對比增強 CT 是評估腎腫塊特性與分期常用的一線工具（若對比禁忌可考慮 MRI 等替代）。"
  },


  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0001",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜A 概論" },
    "stem": "有關中樞神經感染單純疹病毒（HSV）診斷工具中的 HSV 腦脊髓液 PCR，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "敏感性（sensitivity）及專一性（specificity）都超過 90%" },
      { "key": "B", "text": "在發病 72 小時內，腦脊髓液 HSV PCR 有可能呈現陰性" },
      { "key": "C", "text": "腦脊髓液 HSV PCR 的陽性率會隨病程逐漸降低，發病超過 14 天者約僅 20% 仍呈陽性" },
      { "key": "D", "text": "抗病毒治療會使 HSV PCR 陽性率大幅下降，治療 3 天後陽性率即低於 10%" }
    ],
    "answer": "D",
    "explanation": "HSV CSF PCR 早期（<72 小時）可偽陰性；病程較久（約 8–14 天後）才會逐步下降，>14 天仍可能有部分患者維持陽性。單純治療 3 天就降到 <10% 並不正確。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜結核性腦膜炎" },
    "stem": "有關結核性腦膜炎的敘述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "腦脊髓液檢查通常會有淋巴球增多（lymphocytic pleocytosis，約 10–500 cells/µL）" },
      { "key": "B", "text": "腦脊髓液檢查通常葡萄糖濃度會下降（約 20–40 mg/dL）" },
      { "key": "C", "text": "文獻報告少於一半病人腦脊髓液 acid-fast stain 會呈陽性" },
      { "key": "D", "text": "腦脊髓液結核菌 PCR 已經取代培養，成為最主要診斷工具" }
    ],
    "answer": "D",
    "explanation": "TB meningitis 的 PCR 有助診斷，但培養仍是重要（含藥敏）工具，PCR 不能完全取代培養。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜細菌性腦膜炎（診斷）" },
    "stem": "針對細菌性腦膜炎病人的診斷，下列有關腦脊髓液（CSF）檢查之敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "超過一半病人的 CSF 會有 PMN 白血球增加至 >100 cells/µL 現象" },
      { "key": "B", "text": "超過一半病人的 CSF/serum glucose 比值 <0.4" },
      { "key": "C", "text": "超過一半病人的 CSF 細菌培養會是陽性" },
      { "key": "D", "text": "CSF Gram stain 幫助不大，只有約 20% 可以看到致病原" }
    ],
    "answer": "D",
    "explanation": "Gram stain 是細菌性腦膜炎的重要快速檢驗之一，敏感性常見可達約 60–80%，特異性也高；說只有約 20% 幫助不大是錯的。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜腦膜炎雙球菌" },
    "stem": "某新兵訓練中心爆發多名新兵發燒、頭痛、嘔吐、理學檢查為頸部僵硬、出血性皮疹，腦脊髓液染色為革蘭氏陰性雙球菌。下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "病人必須採負壓隔離（空氣隔離防護措施）" },
      { "key": "B", "text": "該病原菌是 Neisseria meningitidis" },
      { "key": "C", "text": "抗生素投藥 24 小時後，一般病人即不具有傳染性" },
      { "key": "D", "text": "治療藥物為 penicillin 或 ceftriaxone" }
    ],
    "answer": "A",
    "explanation": "腦膜炎雙球菌主要採飛沫防護（droplet precautions）；不需要負壓空氣隔離。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_CNS_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜甲 中樞神經感染｜細菌性腦膜炎" },
    "stem": "關於 bacterial meningitis 的敘述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "CSF opening pressure 常大於 180 mmH2O" },
      { "key": "B", "text": "CSF/serum glucose ratio 大於 0.4" },
      { "key": "C", "text": "CSF protein 上升，常大於 45 mg/dL" },
      { "key": "D", "text": "CSF Gram stain 陽性率可 >50%" }
    ],
    "answer": "B",
    "explanation": "細菌性腦膜炎常見 CSF/serum glucose ratio 降低（常 <0.4），因此「大於 0.4」是錯的。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0002",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜蜂窩性組織炎" },
    "stem": "關於蜂窩性組織炎的致病菌描述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "經由切片（punch biopsy）培養陽性結果的機會可高達 70%" },
      { "key": "B", "text": "鏈球菌（streptococci）在下肢循環不良的病人常導致反覆感染" },
      { "key": "C", "text": "被貓狗咬傷易產生厭氧菌相關感染" },
      { "key": "D", "text": "綠膿桿菌可見於被鐵釘穿刺傷造成的傷口感染" }
    ],
    "answer": "A",
    "explanation": "蜂窩性組織炎用切片或針吸找菌的陽性率普遍偏低（約 20–30%），臨床不常靠此常規檢出致病菌。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜水泡/大水泡皮損" },
    "stem": "當皮膚軟組織感染合併水泡（vesicles or bullae）時，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "Coxsackievirus 常好發於小孩，小水泡多分布於手腳或嘴巴" },
      { "key": "B", "text": "Vibrio vulnificus 的危險因子為接觸淡水" },
      { "key": "C", "text": "Staphylococcal scalded skin syndrome 與 toxic epidermal necrolysis 外觀不易分辨，切片可助鑑別" },
      { "key": "D", "text": "水痘若呈紅黑色、紅腫快速蔓延或合併局部感覺異常，需把壞死性筋膜炎列入鑑別" }
    ],
    "answer": "B",
    "explanation": "Vibrio vulnificus 的高風險暴露典型是海水/海產相關，而不是淡水。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜Vibrio vulnificus" },
    "stem": "40 歲男性有肝硬化病史。夏天在海邊釣魚時被魚刺刺傷左腳，隔天左腳紅腫熱痛，出現紫紅色水泡且有休克現象。最可能之致病菌為何？",
    "options": [
      { "key": "A", "text": "Staphylococcus aureus" },
      { "key": "B", "text": "Streptococcus pyogenes" },
      { "key": "C", "text": "Pseudomonas aeruginosa" },
      { "key": "D", "text": "Vibrio vulnificus" }
    ],
    "answer": "D",
    "explanation": "肝硬化 + 海水暴露/海產相關傷口 + 快速進展水泡與休克，是 Vibrio vulnificus 的典型高風險情境。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜Vibrio vulnificus（治療）" },
    "stem": "承上題，下列何種抗生素治療對該病人最為恰當？",
    "options": [
      { "key": "A", "text": "Vancomycin + gentamicin" },
      { "key": "B", "text": "Clindamycin + penicillin" },
      { "key": "C", "text": "Ceftazidime + tetracycline" },
      { "key": "D", "text": "Cefazolin + amikacin" }
    ],
    "answer": "C",
    "explanation": "Vibrio vulnificus 建議以可涵蓋該菌的第三代頭孢菌素（如 ceftazidime）合併 tetracycline 類，以兼顧療效並抑制毒素相關嚴重病程。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜經驗性用藥" },
    "stem": "皮膚軟組織感染之經驗性抗微生物製劑選擇（無藥物過敏、無其他慢性病），下列何者作為第一線治療最不恰當？",
    "options": [
      { "key": "A", "text": "狗咬傷：amoxicillin-clavulanate 或 ampicillin-sulbactam" },
      { "key": "B", "text": "帶狀疱疹（免疫正常，>50 歲）：acyclovir" },
      { "key": "C", "text": "蜂窩性組織炎（staphylococcal or streptococcal）：vancomycin" },
      { "key": "D", "text": "壞死性筋膜炎：可同時涵蓋嗜氧菌與厭氧菌的抗生素組合" }
    ],
    "answer": "C",
    "explanation": "Vancomycin 通常保留於 MRSA 或高度抗藥性疑慮；一般單純蜂窩性組織炎（以 MSSA/鏈球菌為主）不會以 vancomycin 作第一線。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0007",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜接觸史與病原" },
    "stem": "引起皮膚軟組織感染的病原菌可能有不同接觸史或表現形態，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "Pseudomonas：hot-tub folliculitis" },
      { "key": "B", "text": "Streptococcus pyogenes：lymphangitis" },
      { "key": "C", "text": "Treponema pallidum：露珠狀水泡（dewdrop vesicle）" },
      { "key": "D", "text": "HSV-1：唇邊水泡" }
    ],
    "answer": "C",
    "explanation": "「露珠狀水泡」典型描述較偏向水痘/帶狀疱疹等疱疹病毒皮疹；梅毒常見為無痛性潰瘍或後續廣泛皮疹，非此典型表現。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0008",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜壞死性筋膜炎（臨床）" },
    "stem": "肝硬化病人釣魚時腳被牡蠣殼割傷後，紅腫迅速擴散並出現水泡與組織壞死且發燒發冷。關於該病人疾病，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "需詳細詢問病人接觸史，包含海水暴露史" },
      { "key": "B", "text": "若無海水暴露史，即可排除壞死性筋膜炎" },
      { "key": "C", "text": "食用未煮熟的海鮮也有可能引發嚴重軟組織感染" },
      { "key": "D", "text": "若皮膚未明顯發紅但病人表示劇烈疼痛，仍不可排除壞死性筋膜炎" }
    ],
    "answer": "B",
    "explanation": "壞死性筋膜炎的關鍵是臨床表現（進展快、疼痛與外觀不成比例等），不是只有海水暴露才會發生；無海水暴露也不能排除。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0009",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜壞死性筋膜炎（處置）" },
    "stem": "承上題，關於病人處置，下列敘述何者錯誤？",
    "options": [
      { "key": "A", "text": "可用影像（如 CT）評估病灶範圍，但不應延誤關鍵處置" },
      { "key": "B", "text": "儘快留取感染部位檢體並給予適當抗生素" },
      { "key": "C", "text": "聯絡外科進行清創處理" },
      { "key": "D", "text": "若病人最後死亡，主要與細菌侵犯組織有關，與毒素無關" }
    ],
    "answer": "D",
    "explanation": "壞死性筋膜炎（尤其某些菌種）可有嚴重毒素相關全身反應與休克；死亡機轉不僅是局部組織侵犯。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_SSTI_Q0010",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜乙 軟組織感染｜Vibrio vulnificus（海鮮暴露）" },
    "stem": "70 歲肝硬化病人，近來自行剝生蠔食用後出現發燒兩天，今日出現水泡且到院時血壓 90/50 mmHg。最可能感染之病原菌為何？",
    "options": [
      { "key": "A", "text": "Staphylococcus aureus" },
      { "key": "B", "text": "Vibrio vulnificus" },
      { "key": "C", "text": "Group A streptococcus" },
      { "key": "D", "text": "Klebsiella pneumoniae" }
    ],
    "answer": "B",
    "explanation": "肝硬化 + 生蠔/海鮮暴露 + 水泡性皮膚病灶與休克，非常典型指向 Vibrio vulnificus。"
  },

  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0003",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜CAUTI" },
    "stem": "導管長期置放是造成醫療照護相關感染的常見危險因子。導尿管置放後每日發生尿路感染的機會約為多少？",
    "options": [
      { "key": "A", "text": "0.03%–0.07%" },
      { "key": "B", "text": "0.3%–0.7%" },
      { "key": "C", "text": "3%–7%" },
      { "key": "D", "text": "30%–70%" }
    ],
    "answer": "C",
    "explanation": "CAUTI 的風險會隨留置天數上升；經典數字是「每日約 3–7%」的感染風險。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0004",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜重症腹瀉菌血症（題組）" },
    "stem": "80 歲肝硬化病人因腹痛、腹瀉、發燒住院，血壓偏低且有黃疸，糞便與血液培養均長出 Campylobacter jejuni。在藥敏報告出來前，何者為最適當的抗生素治療？",
    "options": [
      { "key": "A", "text": "Trimethoprim-sulfamethoxazole" },
      { "key": "B", "text": "Metronidazole" },
      { "key": "C", "text": "Ampicillin" },
      { "key": "D", "text": "Carbapenem" }
    ],
    "answer": "D",
    "explanation": "此題情境為重症且合併菌血症/敗血傾向，經驗性用藥需以涵蓋力更足的方案優先；ampicillin 可能因抗藥性與嚴重度而不適合作為首選。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0005",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜旅行者腹瀉/食物中毒（觀念題）" },
    "stem": "關於細菌性食物中毒與旅行者腹瀉（traveler’s diarrhea）的敘述，下列何者錯誤？",
    "options": [
      { "key": "A", "text": "潛伏期最短的致病菌常見為 Staphylococcus aureus 與 Bacillus cereus（嘔吐型）" },
      { "key": "B", "text": "Shigella spp 只能經由污染的飲水與食物傳播，不會人對人直接傳染" },
      { "key": "C", "text": "Shigella spp、Entamoeba histolytica、Giardia lamblia 的感染劑量通常遠低於 Vibrio cholerae" },
      { "key": "D", "text": "霍亂弧菌腹瀉主要因腸毒素，糞便多為米湯樣且很少白血球" }
    ],
    "answer": "B",
    "explanation": "Shigella 也可透過糞口途徑人傳人（尤其在密集生活環境），不只靠食物/飲水。"
  },
  {
    "id": "MED3_RENAL_INF_ORI_UTI_Q0006",
    "source_type": "original",
    "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
    "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜CAUTI（預防）" },
    "stem": "下列關於導管相關尿路感染（CAUTI）的敘述，何者正確？",
    "options": [
      { "key": "A", "text": "常規使用抗生素塗抹於尿道口是預防 CAUTI 最有效的措施" },
      { "key": "B", "text": "常規口服抗生素預防 CAUTI 是實證強烈建議的措施" },
      { "key": "C", "text": "CAUTI 的發生與導尿管材質品質關係最大" },
      { "key": "D", "text": "經尿管沖洗膀胱，即使加入抗生素，仍可能增加 CAUTI 的機會" }
    ],
    "answer": "D",
    "explanation": "常規局部/全身抗生素預防或膀胱灌洗並非標準預防策略，反而可能增加風險；核心仍是減少不必要置管、無菌置放與及早移除。"
  },

{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜無症狀菌尿" },
  "stem": "下列何者屬於「無症狀菌尿（asymptomatic bacteriuria）」通常建議治療的族群？",
  "options": [
    { "key": "A", "text": "健康非孕女性" },
    { "key": "B", "text": "長照機構住民但無泌尿症狀" },
    { "key": "C", "text": "孕婦" },
    { "key": "D", "text": "老年男性僅有混濁尿" }
  ],
  "answer": "C",
  "explanation": "無症狀菌尿一般不治療；例外最重要的是孕婦（以及預計進行可能造成黏膜出血的泌尿道侵入性處置）。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜無症狀菌尿" },
  "stem": "下列何者為「無症狀菌尿」不建議常規篩檢與治療的主要理由？",
  "options": [
    { "key": "A", "text": "會增加抗藥性與藥物副作用，且多數不改善預後" },
    { "key": "B", "text": "因為無症狀菌尿多為病毒造成" },
    { "key": "C", "text": "治療會造成永久腎衰竭" },
    { "key": "D", "text": "治療會誘發敗血症" }
  ],
  "answer": "A",
  "explanation": "大多數族群治療無症狀菌尿不改善臨床結果，反而增加抗生素副作用與抗藥性壓力。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜腎盂腎炎" },
  "stem": "關於急性腎盂腎炎（pyelonephritis）的臨床表現，下列何者最典型？",
  "options": [
    { "key": "A", "text": "頻尿、急尿但無發燒" },
    { "key": "B", "text": "發燒、寒顫合併肋脊角叩擊痛（CVA tenderness）" },
    { "key": "C", "text": "單純尿液混濁但無症狀" },
    { "key": "D", "text": "只有蛋白尿" }
  ],
  "answer": "B",
  "explanation": "腎盂腎炎屬上泌尿道感染，常見全身症狀（發燒/寒顫）與 CVA tenderness。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜複雜性 UTI" },
  "stem": "下列何者最符合複雜性 UTI（complicated UTI）的情境？",
  "options": [
    { "key": "A", "text": "健康非孕女性單純膀胱炎" },
    { "key": "B", "text": "男性 UTI" },
    { "key": "C", "text": "症狀輕微就一定是單純" },
    { "key": "D", "text": "尿培養陰性" }
  ],
  "answer": "B",
  "explanation": "男性、尿路結構/功能異常、阻塞、導尿管、免疫低下、孕婦等通常視為複雜性 UTI，需要更完整評估與療程。"
},
{
  "id": "MED3_RENAL_INF_ORI_UTI_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜丁 泌尿道感染｜導管相關" },
  "stem": "關於導管相關尿路感染（CAUTI）的預防，下列何者最正確？",
  "options": [
    { "key": "A", "text": "常規使用預防性抗生素最有效" },
    { "key": "B", "text": "最重要是避免不必要置管並盡早移除" },
    { "key": "C", "text": "每日以抗生素溶液沖洗導尿管" },
    { "key": "D", "text": "只要尿液混濁就需更換導尿管並治療" }
  ],
  "answer": "B",
  "explanation": "CAUTI 核心是「減少置管天數」：避免不必要留置、無菌置放、維持封閉引流系統、盡早移除。"
},
{
  "id": "MED3_RENAL_INF_ORI_GI_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜戊 腸胃道感染｜Clostridioides difficile" },
  "stem": "病人近期使用抗生素後出現水樣腹瀉，最需要優先考慮哪一種病原？",
  "options": [
    { "key": "A", "text": "Vibrio cholerae" },
    { "key": "B", "text": "Clostridioides difficile" },
    { "key": "C", "text": "Giardia lamblia" },
    { "key": "D", "text": "Norovirus" }
  ],
  "answer": "B",
  "explanation": "抗生素相關腹瀉的重要鑑別是 C. difficile（偽膜性腸炎），需依臨床與糞便檢驗評估並及早治療。"
},
{
  "id": "MED3_RENAL_INF_ORI_GI_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜戊 腸胃道感染｜EHEC" },
  "stem": "疑似腸出血性大腸桿菌（EHEC）感染之血便病人，下列何者最不建議？",
  "options": [
    { "key": "A", "text": "補充水分與支持性療法" },
    { "key": "B", "text": "避免止瀉藥" },
    { "key": "C", "text": "例行性使用抗生素" },
    { "key": "D", "text": "監測溶血尿毒症候群（HUS）徵象" }
  ],
  "answer": "C",
  "explanation": "EHEC 相關血便需小心 HUS；抗生素與止瀉藥可能增加風險，因此多以支持性療法為主並密切追蹤。"
},
{
  "id": "MED3_RENAL_INF_ORI_GI_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜戊 腸胃道感染｜霍亂" },
  "stem": "霍亂（cholera）最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "高燒合併血便" },
    { "key": "B", "text": "米湯樣大量水瀉，脫水明顯" },
    { "key": "C", "text": "腹瀉伴大量白血球與膿便" },
    { "key": "D", "text": "腹瀉伴顯著黃疸" }
  ],
  "answer": "B",
  "explanation": "霍亂腸毒素造成分泌性水瀉，典型是米湯樣大量腹瀉與嚴重脫水；治療核心是快速補液。"
},
{
  "id": "MED3_RENAL_INF_ORI_ARTHR_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜己 感染性關節炎" },
  "stem": "成人急性單一大關節紅腫熱痛合併發燒，下列何者是最重要的下一步？",
  "options": [
    { "key": "A", "text": "先給 NSAIDs 觀察 48 小時" },
    { "key": "B", "text": "立即抽取關節液做檢驗（cell count、Gram stain、culture）" },
    { "key": "C", "text": "只照 X 光即可排除感染" },
    { "key": "D", "text": "等血液培養結果出來再處理" }
  ],
  "answer": "B",
  "explanation": "感染性關節炎屬急症，關節液檢驗與培養是診斷關鍵，並需及早引流與抗生素治療。"
},
{
  "id": "MED3_RENAL_INF_ORI_ARTHR_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜己 感染性關節炎" },
  "stem": "感染性關節炎之關節液分析，下列哪一項最支持細菌性關節炎？",
  "options": [
    { "key": "A", "text": "WBC < 2,000/µL 且以單核球為主" },
    { "key": "B", "text": "WBC > 50,000/µL 且以多核球為主" },
    { "key": "C", "text": "只有尿酸結晶" },
    { "key": "D", "text": "葡萄糖正常且蛋白極低" }
  ],
  "answer": "B",
  "explanation": "細菌性關節炎常見關節液高 WBC（常 >50,000/µL）且 PMN 為主；仍需配合 Gram stain/culture。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜β-lactam 機轉" },
  "stem": "β-lactam 類抗生素（如 penicillin、cephalosporin）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 30S 核糖體蛋白合成" },
    { "key": "B", "text": "抑制細胞壁合成（binding PBPs）" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制葉酸代謝" }
  ],
  "answer": "B",
  "explanation": "β-lactam 透過結合 penicillin-binding proteins（PBPs）抑制肽聚醣交聯，造成細胞壁合成受阻。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜glycopeptide" },
  "stem": "Vancomycin 的主要抗菌標的為何？",
  "options": [
    { "key": "A", "text": "抑制 PBPs（transpeptidase）" },
    { "key": "B", "text": "結合 D-Ala-D-Ala 抑制細胞壁合成" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制 50S 核糖體" }
  ],
  "answer": "B",
  "explanation": "Vancomycin 為 glycopeptide，透過結合 D-Ala-D-Ala 末端阻斷肽聚醣延長與交聯。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜aminoglycoside" },
  "stem": "Aminoglycoside（如 gentamicin）最典型的作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 50S 核糖體轉位（translocation）" },
    { "key": "B", "text": "抑制 30S 核糖體造成錯誤閱讀，具殺菌性" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "抑制細胞膜合成" }
  ],
  "answer": "B",
  "explanation": "Aminoglycoside 作用於 30S，造成 mRNA 誤讀與蛋白質合成異常，通常具濃度依賴性殺菌效果。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜fluoroquinolone" },
  "stem": "Fluoroquinolone 類（如 levofloxacin）的主要作用標的是哪一種酵素？",
  "options": [
    { "key": "A", "text": "DNA gyrase / topoisomerase" },
    { "key": "B", "text": "RNA polymerase" },
    { "key": "C", "text": "Dihydrofolate reductase" },
    { "key": "D", "text": "Peptidyl transferase" }
  ],
  "answer": "A",
  "explanation": "Fluoroquinolone 抑制 DNA gyrase 與 topoisomerase IV，干擾 DNA 複製。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜TMP-SMX" },
  "stem": "Trimethoprim-sulfamethoxazole（TMP-SMX）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "雙重抑制葉酸代謝途徑" },
    { "key": "C", "text": "抑制 30S 核糖體" },
    { "key": "D", "text": "破壞細胞膜" }
  ],
  "answer": "B",
  "explanation": "SMX 抑制 dihydropteroate synthase、TMP 抑制 dihydrofolate reductase，形成葉酸代謝的序列阻斷。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜ESBL" },
  "stem": "ESBL（extended-spectrum β-lactamase）產生菌最直接造成哪一類藥物治療困難？",
  "options": [
    { "key": "A", "text": "第一/二/三代 cephalosporin" },
    { "key": "B", "text": "vancomycin" },
    { "key": "C", "text": "metronidazole" },
    { "key": "D", "text": "daptomycin" }
  ],
  "answer": "A",
  "explanation": "ESBL 可水解多數 penicillin 與 cephalosporin（含第三代），臨床常需考慮 carbapenem 或依藥敏選擇替代方案。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜MRSA" },
  "stem": "MRSA 對 β-lactam 抗藥性的主要機轉為何？",
  "options": [
    { "key": "A", "text": "產生 ESBL" },
    { "key": "B", "text": "改變 PBP（PBP2a，mecA）降低 β-lactam 結合" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "增加細胞膜通透性" }
  ],
  "answer": "B",
  "explanation": "MRSA 主要為 mecA 編碼的 PBP2a 使 β-lactam 親和力下降，導致廣泛 β-lactam 抗藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜VRE" },
  "stem": "Vancomycin-resistant Enterococcus（VRE）最典型的抗藥性機轉為何？",
  "options": [
    { "key": "A", "text": "改變細胞壁末端由 D-Ala-D-Ala 變為 D-Ala-D-Lac" },
    { "key": "B", "text": "產生 β-lactamase" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "產生外毒素" }
  ],
  "answer": "A",
  "explanation": "VRE 透過改變肽聚醣前驅物末端（D-Ala-D-Lac）使 vancomycin 難以結合。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜流感" },
  "stem": "流感（influenza）抗病毒藥物 oseltamivir 的主要作用標的是哪一個病毒蛋白？",
  "options": [
    { "key": "A", "text": "hemagglutinin" },
    { "key": "B", "text": "neuraminidase" },
    { "key": "C", "text": "reverse transcriptase" },
    { "key": "D", "text": "protease" }
  ],
  "answer": "B",
  "explanation": "Oseltamivir 為 neuraminidase inhibitor，可抑制病毒釋放與傳播。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜HSV/VZV" },
  "stem": "Acyclovir 的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "抑制病毒 DNA polymerase（需先被病毒 thymidine kinase 活化）" },
    { "key": "C", "text": "抑制病毒 neuraminidase" },
    { "key": "D", "text": "抑制病毒 protease" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 為核苷類似物，先由病毒 thymidine kinase 磷酸化活化，再抑制病毒 DNA polymerase。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜EBV" },
  "stem": "感染性單核球增多症（infectious mononucleosis, EBV）常見下列哪一組臨床特徵？",
  "options": [
    { "key": "A", "text": "咽喉痛、發燒、後頸淋巴結腫大" },
    { "key": "B", "text": "腹瀉、黃疸、米湯樣便" },
    { "key": "C", "text": "無痛性潰瘍、掌蹠疹" },
    { "key": "D", "text": "劇烈腹痛、反跳痛" }
  ],
  "answer": "A",
  "explanation": "EBV 常見發燒、咽炎、淋巴結腫大（常後頸為主），並可見 atypical lymphocytosis。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜定義" },
  "stem": "下列何者符合 AIDS 的臨床定義概念之一？",
  "options": [
    { "key": "A", "text": "任何一次 HIV 抗體陽性" },
    { "key": "B", "text": "CD4 下降（如 <200/µL）或出現特定機會性感染/惡性腫瘤" },
    { "key": "C", "text": "只有發燒與淋巴結腫大" },
    { "key": "D", "text": "病毒量下降到不可偵測" }
  ],
  "answer": "B",
  "explanation": "AIDS 的核心為免疫缺陷程度（常用 CD4 閾值）或出現指標性機會性感染/腫瘤。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜機會性感染" },
  "stem": "HIV 病人 CD4 <200/µL 時，最典型需要預防性用藥的機會性感染是哪一種？",
  "options": [
    { "key": "A", "text": "Pneumocystis jirovecii pneumonia（PJP）" },
    { "key": "B", "text": "流感" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "CD4 <200/µL 時 PJP 風險上升，典型以 TMP-SMX 作為預防性用藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜治療原則" },
  "stem": "下列何者最符合現代抗反轉錄病毒治療（ART）的基本原則？",
  "options": [
    { "key": "A", "text": "單一藥物治療即可避免抗藥性" },
    { "key": "B", "text": "合併多藥（通常至少 3 藥/2 類）以抑制病毒並降低抗藥性" },
    { "key": "C", "text": "只有出現 AIDS 才需開始治療" },
    { "key": "D", "text": "病毒量不可偵測後即可停藥" }
  ],
  "answer": "B",
  "explanation": "ART 以合併療法達到持續病毒抑制並降低抗藥性；一般不建議隨意停藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Cryptococcus" },
  "stem": "Cryptococcus neoformans 感染最典型造成哪一種嚴重臨床表現？",
  "options": [
    { "key": "A", "text": "腦膜炎（特別在免疫低下者）" },
    { "key": "B", "text": "急性化膿性關節炎（最常見）" },
    { "key": "C", "text": "猝死型心肌炎" },
    { "key": "D", "text": "典型為細菌性膿瘍" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在免疫低下（如 HIV）常引起亞急性腦膜炎，是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus" },
  "stem": "侵襲性 aspergillosis 之高危險族群最典型是哪一種？",
  "options": [
    { "key": "A", "text": "健康成人上呼吸道感染" },
    { "key": "B", "text": "長期嗜中性球低下或接受造血幹細胞移植者" },
    { "key": "C", "text": "單純膽結石" },
    { "key": "D", "text": "單純高血壓" }
  ],
  "answer": "B",
  "explanation": "侵襲性 aspergillosis 常見於嚴重免疫抑制（嗜中性球低下、移植、長期高劑量類固醇等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Candida" },
  "stem": "下列何者最常見為侵襲性 Candida 感染（candidemia）的危險因子？",
  "options": [
    { "key": "A", "text": "長期中心靜脈導管與廣效抗生素使用" },
    { "key": "B", "text": "規則運動" },
    { "key": "C", "text": "單純輕微感冒" },
    { "key": "D", "text": "高纖飲食" }
  ],
  "answer": "A",
  "explanation": "candidemia 常與 ICU、中心靜脈導管、TPN、廣效抗生素、免疫低下等相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Giardia" },
  "stem": "Giardia lamblia 感染最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "大量血便與高燒" },
    { "key": "B", "text": "油脂便、腹脹與吸收不良（foul-smelling diarrhea）" },
    { "key": "C", "text": "米湯樣水瀉" },
    { "key": "D", "text": "皮膚水泡與休克" }
  ],
  "answer": "B",
  "explanation": "Giardia 常造成吸收不良與脂肪便、腹脹；常與山泉水/露營飲水等暴露相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Entamoeba histolytica" },
  "stem": "阿米巴感染（Entamoeba histolytica）較典型的臨床組合為何？",
  "options": [
    { "key": "A", "text": "血便/黏液便，且可合併肝膿瘍" },
    { "key": "B", "text": "米湯樣水瀉且無發炎" },
    { "key": "C", "text": "單純咽喉痛與後頸淋巴結腫大" },
    { "key": "D", "text": "皮膚蜂窩性組織炎為主" }
  ],
  "answer": "A",
  "explanation": "E. histolytica 可造成侵襲性腸炎（血便）並可經門靜脈造成肝膿瘍，是經典考點。"
},

{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜β-lactam 機轉" },
  "stem": "β-lactam 類抗生素（如 penicillin、cephalosporin）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 30S 核糖體蛋白合成" },
    { "key": "B", "text": "抑制細胞壁合成（binding PBPs）" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制葉酸代謝" }
  ],
  "answer": "B",
  "explanation": "β-lactam 透過結合 penicillin-binding proteins（PBPs）抑制肽聚醣交聯，造成細胞壁合成受阻。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜glycopeptide" },
  "stem": "Vancomycin 的主要抗菌標的為何？",
  "options": [
    { "key": "A", "text": "抑制 PBPs（transpeptidase）" },
    { "key": "B", "text": "結合 D-Ala-D-Ala 抑制細胞壁合成" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制 50S 核糖體" }
  ],
  "answer": "B",
  "explanation": "Vancomycin 為 glycopeptide，透過結合 D-Ala-D-Ala 末端阻斷肽聚醣延長與交聯。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜aminoglycoside" },
  "stem": "Aminoglycoside（如 gentamicin）最典型的作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 50S 核糖體轉位（translocation）" },
    { "key": "B", "text": "抑制 30S 核糖體造成錯誤閱讀，具殺菌性" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "抑制細胞膜合成" }
  ],
  "answer": "B",
  "explanation": "Aminoglycoside 作用於 30S，造成 mRNA 誤讀與蛋白質合成異常，通常具濃度依賴性殺菌效果。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜fluoroquinolone" },
  "stem": "Fluoroquinolone 類（如 levofloxacin）的主要作用標的是哪一種酵素？",
  "options": [
    { "key": "A", "text": "DNA gyrase / topoisomerase" },
    { "key": "B", "text": "RNA polymerase" },
    { "key": "C", "text": "Dihydrofolate reductase" },
    { "key": "D", "text": "Peptidyl transferase" }
  ],
  "answer": "A",
  "explanation": "Fluoroquinolone 抑制 DNA gyrase 與 topoisomerase IV，干擾 DNA 複製。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜TMP-SMX" },
  "stem": "Trimethoprim-sulfamethoxazole（TMP-SMX）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "雙重抑制葉酸代謝途徑" },
    { "key": "C", "text": "抑制 30S 核糖體" },
    { "key": "D", "text": "破壞細胞膜" }
  ],
  "answer": "B",
  "explanation": "SMX 抑制 dihydropteroate synthase、TMP 抑制 dihydrofolate reductase，形成葉酸代謝的序列阻斷。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜ESBL" },
  "stem": "ESBL（extended-spectrum β-lactamase）產生菌最直接造成哪一類藥物治療困難？",
  "options": [
    { "key": "A", "text": "第一/二/三代 cephalosporin" },
    { "key": "B", "text": "vancomycin" },
    { "key": "C", "text": "metronidazole" },
    { "key": "D", "text": "daptomycin" }
  ],
  "answer": "A",
  "explanation": "ESBL 可水解多數 penicillin 與 cephalosporin（含第三代），臨床常需考慮 carbapenem 或依藥敏選擇替代方案。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜MRSA" },
  "stem": "MRSA 對 β-lactam 抗藥性的主要機轉為何？",
  "options": [
    { "key": "A", "text": "產生 ESBL" },
    { "key": "B", "text": "改變 PBP（PBP2a，mecA）降低 β-lactam 結合" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "增加細胞膜通透性" }
  ],
  "answer": "B",
  "explanation": "MRSA 主要為 mecA 編碼的 PBP2a 使 β-lactam 親和力下降，導致廣泛 β-lactam 抗藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜VRE" },
  "stem": "Vancomycin-resistant Enterococcus（VRE）最典型的抗藥性機轉為何？",
  "options": [
    { "key": "A", "text": "改變細胞壁末端由 D-Ala-D-Ala 變為 D-Ala-D-Lac" },
    { "key": "B", "text": "產生 β-lactamase" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "產生外毒素" }
  ],
  "answer": "A",
  "explanation": "VRE 透過改變肽聚醣前驅物末端（D-Ala-D-Lac）使 vancomycin 難以結合。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜流感" },
  "stem": "流感（influenza）抗病毒藥物 oseltamivir 的主要作用標的是哪一個病毒蛋白？",
  "options": [
    { "key": "A", "text": "hemagglutinin" },
    { "key": "B", "text": "neuraminidase" },
    { "key": "C", "text": "reverse transcriptase" },
    { "key": "D", "text": "protease" }
  ],
  "answer": "B",
  "explanation": "Oseltamivir 為 neuraminidase inhibitor，可抑制病毒釋放與傳播。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜HSV/VZV" },
  "stem": "Acyclovir 的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "抑制病毒 DNA polymerase（需先被病毒 thymidine kinase 活化）" },
    { "key": "C", "text": "抑制病毒 neuraminidase" },
    { "key": "D", "text": "抑制病毒 protease" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 為核苷類似物，先由病毒 thymidine kinase 磷酸化活化，再抑制病毒 DNA polymerase。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜EBV" },
  "stem": "感染性單核球增多症（infectious mononucleosis, EBV）常見下列哪一組臨床特徵？",
  "options": [
    { "key": "A", "text": "咽喉痛、發燒、後頸淋巴結腫大" },
    { "key": "B", "text": "腹瀉、黃疸、米湯樣便" },
    { "key": "C", "text": "無痛性潰瘍、掌蹠疹" },
    { "key": "D", "text": "劇烈腹痛、反跳痛" }
  ],
  "answer": "A",
  "explanation": "EBV 常見發燒、咽炎、淋巴結腫大（常後頸為主），並可見 atypical lymphocytosis。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜定義" },
  "stem": "下列何者符合 AIDS 的臨床定義概念之一？",
  "options": [
    { "key": "A", "text": "任何一次 HIV 抗體陽性" },
    { "key": "B", "text": "CD4 下降（如 <200/µL）或出現特定機會性感染/惡性腫瘤" },
    { "key": "C", "text": "只有發燒與淋巴結腫大" },
    { "key": "D", "text": "病毒量下降到不可偵測" }
  ],
  "answer": "B",
  "explanation": "AIDS 的核心為免疫缺陷程度（常用 CD4 閾值）或出現指標性機會性感染/腫瘤。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜機會性感染" },
  "stem": "HIV 病人 CD4 <200/µL 時，最典型需要預防性用藥的機會性感染是哪一種？",
  "options": [
    { "key": "A", "text": "Pneumocystis jirovecii pneumonia（PJP）" },
    { "key": "B", "text": "流感" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "CD4 <200/µL 時 PJP 風險上升，典型以 TMP-SMX 作為預防性用藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜治療原則" },
  "stem": "下列何者最符合現代抗反轉錄病毒治療（ART）的基本原則？",
  "options": [
    { "key": "A", "text": "單一藥物治療即可避免抗藥性" },
    { "key": "B", "text": "合併多藥（通常至少 3 藥/2 類）以抑制病毒並降低抗藥性" },
    { "key": "C", "text": "只有出現 AIDS 才需開始治療" },
    { "key": "D", "text": "病毒量不可偵測後即可停藥" }
  ],
  "answer": "B",
  "explanation": "ART 以合併療法達到持續病毒抑制並降低抗藥性；一般不建議隨意停藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Cryptococcus" },
  "stem": "Cryptococcus neoformans 感染最典型造成哪一種嚴重臨床表現？",
  "options": [
    { "key": "A", "text": "腦膜炎（特別在免疫低下者）" },
    { "key": "B", "text": "急性化膿性關節炎（最常見）" },
    { "key": "C", "text": "猝死型心肌炎" },
    { "key": "D", "text": "典型為細菌性膿瘍" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在免疫低下（如 HIV）常引起亞急性腦膜炎，是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus" },
  "stem": "侵襲性 aspergillosis 之高危險族群最典型是哪一種？",
  "options": [
    { "key": "A", "text": "健康成人上呼吸道感染" },
    { "key": "B", "text": "長期嗜中性球低下或接受造血幹細胞移植者" },
    { "key": "C", "text": "單純膽結石" },
    { "key": "D", "text": "單純高血壓" }
  ],
  "answer": "B",
  "explanation": "侵襲性 aspergillosis 常見於嚴重免疫抑制（嗜中性球低下、移植、長期高劑量類固醇等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Candida" },
  "stem": "下列何者最常見為侵襲性 Candida 感染（candidemia）的危險因子？",
  "options": [
    { "key": "A", "text": "長期中心靜脈導管與廣效抗生素使用" },
    { "key": "B", "text": "規則運動" },
    { "key": "C", "text": "單純輕微感冒" },
    { "key": "D", "text": "高纖飲食" }
  ],
  "answer": "A",
  "explanation": "candidemia 常與 ICU、中心靜脈導管、TPN、廣效抗生素、免疫低下等相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Giardia" },
  "stem": "Giardia lamblia 感染最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "大量血便與高燒" },
    { "key": "B", "text": "油脂便、腹脹與吸收不良（foul-smelling diarrhea）" },
    { "key": "C", "text": "米湯樣水瀉" },
    { "key": "D", "text": "皮膚水泡與休克" }
  ],
  "answer": "B",
  "explanation": "Giardia 常造成吸收不良與脂肪便、腹脹；常與山泉水/露營飲水等暴露相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Entamoeba histolytica" },
  "stem": "阿米巴感染（Entamoeba histolytica）較典型的臨床組合為何？",
  "options": [
    { "key": "A", "text": "血便/黏液便，且可合併肝膿瘍" },
    { "key": "B", "text": "米湯樣水瀉且無發炎" },
    { "key": "C", "text": "單純咽喉痛與後頸淋巴結腫大" },
    { "key": "D", "text": "皮膚蜂窩性組織炎為主" }
  ],
  "answer": "A",
  "explanation": "E. histolytica 可造成侵襲性腸炎（血便）並可經門靜脈造成肝膿瘍，是經典考點。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜β-lactam 機轉" },
  "stem": "β-lactam 類抗生素（如 penicillin、cephalosporin）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 30S 核糖體蛋白合成" },
    { "key": "B", "text": "抑制細胞壁合成（binding PBPs）" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制葉酸代謝" }
  ],
  "answer": "B",
  "explanation": "β-lactam 透過結合 penicillin-binding proteins（PBPs）抑制肽聚醣交聯，造成細胞壁合成受阻。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜glycopeptide" },
  "stem": "Vancomycin 的主要抗菌標的為何？",
  "options": [
    { "key": "A", "text": "抑制 PBPs（transpeptidase）" },
    { "key": "B", "text": "結合 D-Ala-D-Ala 抑制細胞壁合成" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "抑制 50S 核糖體" }
  ],
  "answer": "B",
  "explanation": "Vancomycin 為 glycopeptide，透過結合 D-Ala-D-Ala 末端阻斷肽聚醣延長與交聯。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜aminoglycoside" },
  "stem": "Aminoglycoside（如 gentamicin）最典型的作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制 50S 核糖體轉位（translocation）" },
    { "key": "B", "text": "抑制 30S 核糖體造成錯誤閱讀，具殺菌性" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "抑制細胞膜合成" }
  ],
  "answer": "B",
  "explanation": "Aminoglycoside 作用於 30S，造成 mRNA 誤讀與蛋白質合成異常，通常具濃度依賴性殺菌效果。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜fluoroquinolone" },
  "stem": "Fluoroquinolone 類（如 levofloxacin）的主要作用標的是哪一種酵素？",
  "options": [
    { "key": "A", "text": "DNA gyrase / topoisomerase" },
    { "key": "B", "text": "RNA polymerase" },
    { "key": "C", "text": "Dihydrofolate reductase" },
    { "key": "D", "text": "Peptidyl transferase" }
  ],
  "answer": "A",
  "explanation": "Fluoroquinolone 抑制 DNA gyrase 與 topoisomerase IV，干擾 DNA 複製。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXMECH_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗生素｜TMP-SMX" },
  "stem": "Trimethoprim-sulfamethoxazole（TMP-SMX）的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "雙重抑制葉酸代謝途徑" },
    { "key": "C", "text": "抑制 30S 核糖體" },
    { "key": "D", "text": "破壞細胞膜" }
  ],
  "answer": "B",
  "explanation": "SMX 抑制 dihydropteroate synthase、TMP 抑制 dihydrofolate reductase，形成葉酸代謝的序列阻斷。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜ESBL" },
  "stem": "ESBL（extended-spectrum β-lactamase）產生菌最直接造成哪一類藥物治療困難？",
  "options": [
    { "key": "A", "text": "第一/二/三代 cephalosporin" },
    { "key": "B", "text": "vancomycin" },
    { "key": "C", "text": "metronidazole" },
    { "key": "D", "text": "daptomycin" }
  ],
  "answer": "A",
  "explanation": "ESBL 可水解多數 penicillin 與 cephalosporin（含第三代），臨床常需考慮 carbapenem 或依藥敏選擇替代方案。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜MRSA" },
  "stem": "MRSA 對 β-lactam 抗藥性的主要機轉為何？",
  "options": [
    { "key": "A", "text": "產生 ESBL" },
    { "key": "B", "text": "改變 PBP（PBP2a，mecA）降低 β-lactam 結合" },
    { "key": "C", "text": "抑制葉酸代謝" },
    { "key": "D", "text": "增加細胞膜通透性" }
  ],
  "answer": "B",
  "explanation": "MRSA 主要為 mecA 編碼的 PBP2a 使 β-lactam 親和力下降，導致廣泛 β-lactam 抗藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_ABXRES_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜庚 抗藥性｜VRE" },
  "stem": "Vancomycin-resistant Enterococcus（VRE）最典型的抗藥性機轉為何？",
  "options": [
    { "key": "A", "text": "改變細胞壁末端由 D-Ala-D-Ala 變為 D-Ala-D-Lac" },
    { "key": "B", "text": "產生 β-lactamase" },
    { "key": "C", "text": "抑制 DNA gyrase" },
    { "key": "D", "text": "產生外毒素" }
  ],
  "answer": "A",
  "explanation": "VRE 透過改變肽聚醣前驅物末端（D-Ala-D-Lac）使 vancomycin 難以結合。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜流感" },
  "stem": "流感（influenza）抗病毒藥物 oseltamivir 的主要作用標的是哪一個病毒蛋白？",
  "options": [
    { "key": "A", "text": "hemagglutinin" },
    { "key": "B", "text": "neuraminidase" },
    { "key": "C", "text": "reverse transcriptase" },
    { "key": "D", "text": "protease" }
  ],
  "answer": "B",
  "explanation": "Oseltamivir 為 neuraminidase inhibitor，可抑制病毒釋放與傳播。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜HSV/VZV" },
  "stem": "Acyclovir 的主要作用機轉為何？",
  "options": [
    { "key": "A", "text": "抑制細胞壁合成" },
    { "key": "B", "text": "抑制病毒 DNA polymerase（需先被病毒 thymidine kinase 活化）" },
    { "key": "C", "text": "抑制病毒 neuraminidase" },
    { "key": "D", "text": "抑制病毒 protease" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 為核苷類似物，先由病毒 thymidine kinase 磷酸化活化，再抑制病毒 DNA polymerase。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒感染｜EBV" },
  "stem": "感染性單核球增多症（infectious mononucleosis, EBV）常見下列哪一組臨床特徵？",
  "options": [
    { "key": "A", "text": "咽喉痛、發燒、後頸淋巴結腫大" },
    { "key": "B", "text": "腹瀉、黃疸、米湯樣便" },
    { "key": "C", "text": "無痛性潰瘍、掌蹠疹" },
    { "key": "D", "text": "劇烈腹痛、反跳痛" }
  ],
  "answer": "A",
  "explanation": "EBV 常見發燒、咽炎、淋巴結腫大（常後頸為主），並可見 atypical lymphocytosis。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜定義" },
  "stem": "下列何者符合 AIDS 的臨床定義概念之一？",
  "options": [
    { "key": "A", "text": "任何一次 HIV 抗體陽性" },
    { "key": "B", "text": "CD4 下降（如 <200/µL）或出現特定機會性感染/惡性腫瘤" },
    { "key": "C", "text": "只有發燒與淋巴結腫大" },
    { "key": "D", "text": "病毒量下降到不可偵測" }
  ],
  "answer": "B",
  "explanation": "AIDS 的核心為免疫缺陷程度（常用 CD4 閾值）或出現指標性機會性感染/腫瘤。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜機會性感染" },
  "stem": "HIV 病人 CD4 <200/µL 時，最典型需要預防性用藥的機會性感染是哪一種？",
  "options": [
    { "key": "A", "text": "Pneumocystis jirovecii pneumonia（PJP）" },
    { "key": "B", "text": "流感" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "CD4 <200/µL 時 PJP 風險上升，典型以 TMP-SMX 作為預防性用藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜治療原則" },
  "stem": "下列何者最符合現代抗反轉錄病毒治療（ART）的基本原則？",
  "options": [
    { "key": "A", "text": "單一藥物治療即可避免抗藥性" },
    { "key": "B", "text": "合併多藥（通常至少 3 藥/2 類）以抑制病毒並降低抗藥性" },
    { "key": "C", "text": "只有出現 AIDS 才需開始治療" },
    { "key": "D", "text": "病毒量不可偵測後即可停藥" }
  ],
  "answer": "B",
  "explanation": "ART 以合併療法達到持續病毒抑制並降低抗藥性；一般不建議隨意停藥。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Cryptococcus" },
  "stem": "Cryptococcus neoformans 感染最典型造成哪一種嚴重臨床表現？",
  "options": [
    { "key": "A", "text": "腦膜炎（特別在免疫低下者）" },
    { "key": "B", "text": "急性化膿性關節炎（最常見）" },
    { "key": "C", "text": "猝死型心肌炎" },
    { "key": "D", "text": "典型為細菌性膿瘍" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在免疫低下（如 HIV）常引起亞急性腦膜炎，是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Aspergillus" },
  "stem": "侵襲性 aspergillosis 之高危險族群最典型是哪一種？",
  "options": [
    { "key": "A", "text": "健康成人上呼吸道感染" },
    { "key": "B", "text": "長期嗜中性球低下或接受造血幹細胞移植者" },
    { "key": "C", "text": "單純膽結石" },
    { "key": "D", "text": "單純高血壓" }
  ],
  "answer": "B",
  "explanation": "侵襲性 aspergillosis 常見於嚴重免疫抑制（嗜中性球低下、移植、長期高劑量類固醇等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_FUNGAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜癸 黴菌感染｜Candida" },
  "stem": "下列何者最常見為侵襲性 Candida 感染（candidemia）的危險因子？",
  "options": [
    { "key": "A", "text": "長期中心靜脈導管與廣效抗生素使用" },
    { "key": "B", "text": "規則運動" },
    { "key": "C", "text": "單純輕微感冒" },
    { "key": "D", "text": "高纖飲食" }
  ],
  "answer": "A",
  "explanation": "candidemia 常與 ICU、中心靜脈導管、TPN、廣效抗生素、免疫低下等相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Giardia" },
  "stem": "Giardia lamblia 感染最典型的臨床表現為何？",
  "options": [
    { "key": "A", "text": "大量血便與高燒" },
    { "key": "B", "text": "油脂便、腹脹與吸收不良（foul-smelling diarrhea）" },
    { "key": "C", "text": "米湯樣水瀉" },
    { "key": "D", "text": "皮膚水泡與休克" }
  ],
  "answer": "B",
  "explanation": "Giardia 常造成吸收不良與脂肪便、腹脹；常與山泉水/露營飲水等暴露相關。"
},
{
  "id": "MED3_RENAL_INF_ORI_PARASITE_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜子 寄生蟲感染｜Entamoeba histolytica" },
  "stem": "阿米巴感染（Entamoeba histolytica）較典型的臨床組合為何？",
  "options": [
    { "key": "A", "text": "血便/黏液便，且可合併肝膿瘍" },
    { "key": "B", "text": "米湯樣水瀉且無發炎" },
    { "key": "C", "text": "單純咽喉痛與後頸淋巴結腫大" },
    { "key": "D", "text": "皮膚蜂窩性組織炎為主" }
  ],
  "answer": "A",
  "explanation": "E. histolytica 可造成侵襲性腸炎（血便）並可經門靜脈造成肝膿瘍，是經典考點。"
},

  {
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜流感" },
  "stem": "下列有關流感之敘述，何者錯誤？",
  "options": [
    { "key": "A", "text": "流行性感冒病毒屬於 RNA 病毒" },
    { "key": "B", "text": "主要傳播方式是透過飛沫傳染與接觸傳染" },
    { "key": "C", "text": "免疫缺損病人及兒童可傳染期較成人病例為長" },
    { "key": "D", "text": "流感快篩陰性，即可排除流感" }
  ],
  "answer": "D",
  "explanation": "流感快篩的敏感度有限（臨床常見約 50–70%），陰性結果不能完全排除流感；若臨床高度懷疑（典型症狀且在流行季），仍應考慮以 PCR 確認或依臨床情境給予抗病毒治療。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜隔離與特殊防護" },
  "stem": "下列那一個致病菌目前沒有效的抗微生物製劑治療，且必須進行特殊隔離，以免傳播給其他人？",
  "options": [
    { "key": "A", "text": "嚴重急性呼吸道症候群（severe acute respiratory syndrome）" },
    { "key": "B", "text": "吸入型炭疽病（anthrax）" },
    { "key": "C", "text": "漢生病（Hansen's disease）" },
    { "key": "D", "text": "流行性感冒" }
  ],
  "answer": "A",
  "explanation": "SARS 為病毒性呼吸道感染，缺乏「有效抗微生物製劑」可直接根治，且具院內傳播風險，需要嚴格感染管制（以飛沫為主，侵入性呼吸道處置時需特別注意氣溶膠風險）。吸入型炭疽不典型人傳人；漢生病傳染力低且可治療；流感以飛沫/接觸隔離為主。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜流感疫苗" },
  "stem": "下列有關注射型流感疫苗之敘述，何者錯誤？",
  "options": [
    { "key": "A", "text": "採肌肉注射" },
    { "key": "B", "text": "年齡 6 個月以下者，不予接種" },
    { "key": "C", "text": "孕婦及免疫不全病人屬於禁忌，不應接種" },
    { "key": "D", "text": "已知對「蛋」之蛋白質過敏者，不予接種" }
  ],
  "answer": "C",
  "explanation": "注射型流感疫苗為肌肉注射，且 6 個月以下不接種；孕婦與免疫不全者並非禁忌，反而常屬高風險族群、一般建議接種以降低重症風險。"
},
{
  "id": "MED3_RENAL_INF_ORI_VIRUS_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜Infectious mononucleosis 鑑別" },
  "stem": "20 歲男性大學生，持續發燒 10 天合併頭痛、肌肉疼痛及喉嚨痛。身體診察有頸部和鼠蹊淋巴腺腫大及軀幹斑丘疹。WBC 4,200/mL，分類：多核球 35%、淋巴球 45%、單核球 15%、非典型淋巴球 5%。GOT 56、GPT 60。最不需要選擇下列何種檢驗？",
  "options": [
    { "key": "A", "text": "HIV test（human immunodeficiency virus I & II）" },
    { "key": "B", "text": "CMV IgM（cytomegalovirus IgM）" },
    { "key": "C", "text": "EB VCA IgM（Epstein–Barr viral capsid antigen IgM）" },
    { "key": "D", "text": "measles IgM" }
  ],
  "answer": "D",
  "explanation": "此臨床圖像（發燒、咽喉痛、淋巴結腫大、皮疹、輕度轉氨酶上升、可見非典型淋巴球）較符合 infectious mononucleosis 類群，常見病原包含 EBV、CMV 與急性 HIV；相較之下 measles IgM 並非優先檢驗。"
},
{
  "id": "MED3_RENAL_INF_ORI_MEASLES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜麻疹" },
  "stem": "1 歲大女嬰出現發燒、咳嗽、流鼻水及結膜炎，發燒後 3–4 天口腔出現柯氏斑點（Koplik's spots），最有可能診斷為何？",
  "options": [
    { "key": "A", "text": "嬰兒玫瑰疹" },
    { "key": "B", "text": "猩紅熱" },
    { "key": "C", "text": "川崎氏症" },
    { "key": "D", "text": "麻疹" }
  ],
  "answer": "D",
  "explanation": "麻疹典型前驅症狀為發燒、咳嗽、鼻炎（coryza）、結膜炎（3C），隨後可見口腔黏膜 Koplik spots，之後出現由頭頸往下的紅疹。"
},
{
  "id": "MED3_RENAL_INF_ORI_MEASLES_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜麻疹" },
  "stem": "下列有關麻疹的敘述，何者錯誤？",
  "options": [
    { "key": "A", "text": "麻疹病毒是一種 RNA 病毒，主要藉由飛沫傳染，亦可經由接觸傳染" },
    { "key": "B", "text": "發病初期的症狀以發燒、鼻炎、結膜炎以及咳嗽為主" },
    { "key": "C", "text": "發病 2 至 4 天後，皮膚上會出現柯氏斑點（Koplik's spots）以及紅疹，由頭部向下移至軀幹" },
    { "key": "D", "text": "施打 MMR 疫苗可以用來預防麻疹、流行性腮腺炎以及德國麻疹" }
  ],
  "answer": "C",
  "explanation": "Koplik's spots 是「口腔黏膜」病灶，通常在出疹前出現；紅疹才是由頭頸往下蔓延。把 Koplik spots 說成在皮膚上出現是不正確的。"
},
{
  "id": "MED3_RENAL_INF_ORI_HERPES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜疱疹相關病毒" },
  "stem": "下列有關皰疹相關病毒的敘述，何者正確？",
  "options": [
    { "key": "A", "text": "免疫正常的人發生過皮膚性帶狀皰疹（herpes zoster），大於 10% 會反覆發作" },
    { "key": "B", "text": "未曾施打水痘（chickenpox）疫苗且未曾感染過水痘者，在接觸水痘病人後有小於 40% 會被感染" },
    { "key": "C", "text": "感染性單核細胞增多症（infectious mononucleosis）的最常見症狀是發燒、喉嚨痛、淋巴結腫大" },
    { "key": "D", "text": "在年輕人，感染性單核細胞增多症的潛伏期為 5–10 天" }
  ],
  "answer": "C",
  "explanation": "感染性單核球增多症典型三聯徵為發燒、咽炎與淋巴結腫大。其潛伏期通常較長（常以數週計），而水痘接觸後的二代傳播率一般不低。"
},
{
  "id": "MED3_RENAL_INF_ORI_RABIES_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 病毒學｜狂犬病暴露後預防（PEP）" },
  "stem": "下列「狂犬病暴露後的疫苗注射」及建議時間，何者正確？",
  "options": [
    { "key": "A", "text": "第 0、3、7、14、28 天，共 5 次" },
    { "key": "B", "text": "第 0、7、14、28 天，共 4 次" },
    { "key": "C", "text": "第 0、7、28 天，共 3 次" },
    { "key": "D", "text": "第 0、14、28 天，共 3 次" }
  ],
  "answer": "A",
  "explanation": "狂犬病暴露後預防（PEP）常見考法為疫苗時程：第 0、3、7、14、28 天共 5 劑（並依暴露風險評估是否需要在傷口周圍注射 RIG）。"
},

  {
  "id": "MED3_RENAL_INF_ORI_ANTIVIRAL_Q0001",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜Acyclovir" },
  "stem": "下列何者最符合 acyclovir 的臨床使用與副作用描述？",
  "options": [
    { "key": "A", "text": "主要治療 CMV；常見骨髓抑制" },
    { "key": "B", "text": "主要治療 HSV/VZV；高劑量或靜脈使用可造成結晶性腎病變" },
    { "key": "C", "text": "主要治療流感；常見肌肉毒性" },
    { "key": "D", "text": "主要治療 HIV；常見乳酸中毒" }
  ],
  "answer": "B",
  "explanation": "Acyclovir 常用於 HSV/VZV；IV 或高劑量可能造成結晶性腎損傷（注意補液、腎功能調整）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ANTIVIRAL_Q0002",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜Ganciclovir/Valganciclovir" },
  "stem": "Ganciclovir（或 valganciclovir）最典型的適應症與重要副作用組合為何？",
  "options": [
    { "key": "A", "text": "治療 CMV；骨髓抑制（neutropenia）" },
    { "key": "B", "text": "治療流感；嚴重肝衰竭" },
    { "key": "C", "text": "治療 HSV；嚴重耳毒性" },
    { "key": "D", "text": "治療 HBV；甲狀腺毒性" }
  ],
  "answer": "A",
  "explanation": "Ganciclovir/valganciclovir 常用於 CMV（如 CMV retinitis 等），重要副作用是骨髓抑制（特別是 neutropenia、thrombocytopenia）。"
},
{
  "id": "MED3_RENAL_INF_ORI_ANTIVIRAL_Q0003",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜辛 抗病毒藥物｜Foscarnet" },
  "stem": "Foscarnet 的臨床定位與典型毒性，下列何者最正確？",
  "options": [
    { "key": "A", "text": "用於抗藥 HSV/CMV；腎毒性與電解質異常（如低鈣）" },
    { "key": "B", "text": "用於流感；骨髓抑制" },
    { "key": "C", "text": "用於 HBV；嚴重貧血" },
    { "key": "D", "text": "用於 RSV；心肌毒性" }
  ],
  "answer": "A",
  "explanation": "Foscarnet 可用於 ganciclovir-resistant CMV 或 acyclovir-resistant HSV；重要不良反應為腎毒性及電解質異常（低 Ca/Mg/K 等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0004",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜檢驗策略" },
  "stem": "HIV 感染的初步篩檢與確認，下列何者最符合一般臨床流程概念？",
  "options": [
    { "key": "A", "text": "只做一次 HIV 抗體快篩陽性即可直接診斷 HIV 感染" },
    { "key": "B", "text": "先做篩檢試驗（如 Ag/Ab），陽性再做確認試驗（分型/補充檢驗或核酸檢測）" },
    { "key": "C", "text": "HIV PCR 只能在 AIDS 才會陽性" },
    { "key": "D", "text": "陰性結果永遠可排除（不需考慮 window period）" }
  ],
  "answer": "B",
  "explanation": "臨床多採「先篩檢、後確認」；並需考量暴露時間與檢驗 window period，必要時重複檢驗或做核酸檢測。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0005",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜PJP 預防" },
  "stem": "下列何者最符合 Pneumocystis jirovecii pneumonia（PJP）預防用藥的典型指徵與首選？",
  "options": [
    { "key": "A", "text": "CD4 <200/µL；首選 TMP-SMX" },
    { "key": "B", "text": "CD4 <500/µL；首選 azithromycin" },
    { "key": "C", "text": "CD4 <50/µL；首選 isoniazid" },
    { "key": "D", "text": "任何 HIV 感染者都需終身 TMP-SMX" }
  ],
  "answer": "A",
  "explanation": "PJP 預防典型門檻為 CD4 <200/µL（或特定高風險情境），首選 TMP-SMX。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0006",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜Toxoplasma 預防" },
  "stem": "HIV 病人若 toxoplasma IgG 陽性且 CD4 過低，最典型需要預防的機會性感染為何？",
  "options": [
    { "key": "A", "text": "Toxoplasma encephalitis（腦炎）" },
    { "key": "B", "text": "流感肺炎" },
    { "key": "C", "text": "霍亂" },
    { "key": "D", "text": "破傷風" }
  ],
  "answer": "A",
  "explanation": "Toxoplasma IgG 陽性代表既往感染；在嚴重免疫抑制（典型 CD4 <100/µL）時有再活化風險，需考慮預防（常用 TMP-SMX）。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0007",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜MAC 預防" },
  "stem": "HIV 病人 CD4 極低時（典型 <50/µL）最需要注意/預防的嚴重散播性感染之一為何？",
  "options": [
    { "key": "A", "text": "Mycobacterium avium complex（MAC）" },
    { "key": "B", "text": "流行性感冒" },
    { "key": "C", "text": "A 型肝炎" },
    { "key": "D", "text": "單純性膀胱炎" }
  ],
  "answer": "A",
  "explanation": "CD4 <50/µL 時 MAC 散播性感染風險顯著上升；是否需要預防用藥取決於是否已有效 ART 與臨床策略，但此門檻與 MAC 是經典考點。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0008",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜CMV" },
  "stem": "AIDS 病人出現視力模糊、飛蚊症，眼底檢查見網膜出血與壞死（典型“pizza pie”外觀），最可能之病原與治療藥物組合為何？",
  "options": [
    { "key": "A", "text": "HSV；acyclovir" },
    { "key": "B", "text": "CMV；ganciclovir/valganciclovir" },
    { "key": "C", "text": "VZV；oseltamivir" },
    { "key": "D", "text": "EBV；amoxicillin-clavulanate" }
  ],
  "answer": "B",
  "explanation": "AIDS 低 CD4 時可見 CMV retinitis；治療以 ganciclovir/valganciclovir（或依抗藥性與狀況選 foscarnet 等）。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0009",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜Cryptococcus" },
  "stem": "HIV 病人亞急性頭痛、發燒，腰椎穿刺顯示 opening pressure 上升，最需要考慮哪一種黴菌性腦膜炎？",
  "options": [
    { "key": "A", "text": "Cryptococcus neoformans" },
    { "key": "B", "text": "Candida albicans" },
    { "key": "C", "text": "Aspergillus fumigatus" },
    { "key": "D", "text": "Dermatophyte" }
  ],
  "answer": "A",
  "explanation": "Cryptococcus 在 AIDS 常造成亞急性腦膜炎，典型可見顱內壓上升，診斷可用 CrAg（cryptococcal antigen）等。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0010",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜PJP 臨床" },
  "stem": "HIV 病人漸進性呼吸困難、乾咳、低氧，胸部影像常見雙側瀰漫性間質性浸潤。最可能診斷為何？",
  "options": [
    { "key": "A", "text": "PJP（Pneumocystis jirovecii pneumonia）" },
    { "key": "B", "text": "典型肺炎鏈球菌肺炎" },
    { "key": "C", "text": "肺結核必然" },
    { "key": "D", "text": "單純急性支氣管炎" }
  ],
  "answer": "A",
  "explanation": "PJP 常表現為亞急性/漸進性呼吸症狀、低氧，影像可呈雙側瀰漫性間質性浸潤（或磨玻璃）。治療多以 TMP-SMX，嚴重低氧時加用類固醇。"
},
{
  "id": "MED3_RENAL_INF_ORI_HIV_Q0011",
  "source_type": "original",
  "book": { "code": "MED_03_RENAL_INF", "title": "三(3) 腎內、感染" },
  "location": { "section": "第二篇 感染科｜壬 HIV｜ART 原則" },
  "stem": "啟動 ART 後病毒量下降、CD4 回升的主要臨床意義，下列何者最正確？",
  "options": [
    { "key": "A", "text": "代表可立即停藥以避免副作用" },
    { "key": "B", "text": "可降低機會性感染與傳播風險，但需持續治療與追蹤" },
    { "key": "C", "text": "代表 HIV 已被根除，不需再追蹤" },
    { "key": "D", "text": "只要病毒量不可偵測就不會再有任何併發症風險" }
  ],
  "answer": "B",
  "explanation": "有效 ART 可降低 OI 與死亡率並顯著降低傳播風險，但仍需長期持續治療與規律追蹤（抗藥性、共病、疫苗與預防策略等）。"
}
  
]
